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Summary
Fasciola hepatica is a trematode parasite with a global distribution, which is respon-
sible for considerable disease and production losses in a range of food producing
species. It is also identified by WHO as a re-emerging neglected tropical disease
associated with endemic and epidemic outbreaks of disease in human populations.
In Europe, F. hepatica is mostly associated with disease in sheep, cattle and goats.
This study reviews the most recent advances in our understanding of the transmis-
sion, diagnosis, epidemiology and the economic impact of fasciolosis. We also focus
on the impact of the spread of resistance to anthelmintics used to control F. hepat-
ica and consider how vaccines might be developed and applied in the context of
the immune-modulation driven by the parasite. Several major research gaps are
identified which, when addressed, will contribute to providing focussed and where
possible, bespoke, advice for farmers on how to integrate stock management and
diagnosis with vaccination and/or targeted treatment to more effectively control
the parasite in the face of increasing the prevalence of infection and spread of
anthelmintic resistance that are likely to be exacerbated by climate change.
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1 | INTRODUCTION
Fasciola hepatica is a trematode parasite found throughout Europe
which affects a range of hosts, including ruminants, horses, wild ani-
mal hosts such as deer, rabbits and hares and humans. Loss of pro-
duction associated with infection and overt clinical disease results in
significant costs to the global farming industry, estimated at over $3
billion per year (Spithill, Smooker, & Copeman, 1999). These costs
are largely unquantified at a national or regional level, whilst at a
farm level, it has been reported that fluke affects milk yield, carcase
composition and extends time to reach slaughter weight (Charlier,
Vercruysse, Morgan, van Dijk, & Williams, 2014; Howell, Baylis,
Smith, Pinchbeck, & Williams, 2015). Evidence from across Europe
suggests that both the awareness and prevalence of infection has
increased in particular regions of Europe, such as southern Sweden
(H€oglund et al., 2010). There are growing concerns about resistance
to flukicides and about drug residues in meat and milk which have
led to restrictions in their use and an increase in meat and milk with-
drawal periods for many products (http://www.noahcompendium.co.uk).
Fasciola hepatica also has the capacity to modulate the host’s
immune system, affecting susceptibility to and diagnosis of other
pathogens including bovine tuberculosis (Claridge et al., 2012).All authors contributed equally to the manuscript and are listed alphabetically.
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This review will focus on fasciolosis in Europe, caused by
F. hepatica and will build on the many recent reviews of all aspects
of fluke biology, to highlight new challenges in controlling the para-
site and to identify gaps where more research is urgently needed
(http://www.discontools.eu). The review highlights the importance of
the snail intermediate host; recent developments in epidemiology of
fasciolosis and the predicted impact of climate change on its preva-
lence and spatial distribution; what improvements in diagnosis are
needed and how better to apply drugs to slow the development and
spread of resistance; and finally we consider gaps in our knowledge
of fluke-driven immunomodulation and how this relates to vaccine
development.
Fasciola hepatica has an indirect life cycle involving lymnaeid snail
intermediate hosts, the principal species in Europe being Galba trun-
catula. Undifferentiated fluke eggs are passed out in the faeces of
infected animals and once washed out of the faeces, the eggs start
to develop, a process dependent on temperature. When a fully
developed egg is given stimuli of increased light and temperature,
the short-lived miracidium is released. It requires water to swim
through and once it finds a suitable lymnaeid snail, it burrows
through the foot and into the body cavity. The fluke multiplies and,
after about 6 weeks, cercariae are released. Again this process is
temperature dependent and a snail infected with a single miracidium
can produce several hundred cercariae, released over a period of
time. The cercariae encyst on the vegetation to form infective
metacercariae. When a grazing animal eats contaminated herbage,
the metacercariae hatch, the newly excysted juveniles burrow
through the gut wall and migrate into the liver. Immature fluke
migrate through the liver parenchyma for 6–8 weeks before entering
into bile ducts, where they mature and start producing eggs that can
then be detected in faeces (reviewed in (Dalton, 1999).
2 | SNAIL BIOLOGY
The presence of the snail intermediate host is essential to the trans-
mission of F. hepatica, and knowledge of the interaction between
snail and parasite is important when considering what drives parasite
transmission. It is also important to understand how events in the
snail influence genetic diversity of parasites in the mammalian host.
To fully understand the epidemiology of Fasciola spp., better knowl-
edge of snail habitats, species of snails acting as intermediate hosts,
and prevalence of F. hepatica infection within the snail are required
(Ca~nete, Yong, Sanchez, Wong, & Gutierrez, 2004).
Although G. truncatula are usually found in semi-aquatic habitats
(Boray, 1969), including drainage furrows, slow moving streams, tem-
porary moist areas and banks of rivers and ponds (Charlier, Soenen
et al., 2014; Rondelaud, Hourdin, Vignoles, Dreyfuss, & Cabaret,
2011; Schweizer et al., 2007), they are resistant to drought and
frost; so will aestivate or hibernate by burying into the mud for
extensive periods (Armour, 1975; Ollerenshaw, 1959; Schweizer
et al., 2007). This means that snail habitats are only readily identifi-
able at certain points through the year, for example in spring/
summer and autumn when there are peaks in the abundance of adult
and juvenile snails, respectively (Charlier, Soenen et al., 2014;
Manga-Gonzalez, Gonzalez-Lanza, & Otero-Merino, 1991; Relf et al.,
2011). The number and size of temporary or secondary habitat vary
from year to year depending on the prevailing weather conditions,
and as a result alters the carrying capacity from one year to the next
(Crossland, 1976). Locating snail habitats on farms is laborious and
dependent on the skills of the personnel involved (Heppleston,
1972); yet detailed characterization of snail habitats is crucial to be
able to predict the risk of fasciolosis at the individual farm level
(Charlier et al., 2011). Using remote sensing methods, particularly soil
moisture data from the new generation of Sentinel satellite systems
together with other technologies, such as detection of environmental
DNA, to identify suitable snail habitat on farms will improve our abil-
ity to predict when and where metacercariae may appear on pasture.
The timing of high-risk periods will vary from region to region, for
example in northern Europe, large numbers of metacercariae appear
in autumn, whilst in southern Europe, risk is greater in winter and
spring (Caminade, Van Dijk, Baylis, & Williams, 2015). Developing
methods to identify when metacercariae appear on pasture and to
quantify risk, will inform grazing and drug control programmes, par-
ticularly if combined with improved diagnostic tests.
In Europe, the main snail intermediate host is G. truncatula, but
Lymnaea palustris, Omphiscola glabra, Radix balthica, Succinea spp.
and Potamopyrgus antipodarum are all reported as potential interme-
diate hosts of F. hepatica (Abrous, Rondelaud, Dreyfuss, & Cabaret,
1999; Caron, Martens, Lempereur, Saegerman, & Losson, 2014;
Dreyfuss, Alarion, Vignoles, & Rondelaud, 2005; Jones, Williams,
Dalesman, & Brophy, 2015; Novobilsky, Kasny, Beran, Rondelaud, &
H€oglund, 2013; Relf, Good, McCarthy, & de Waal, 2009; Rondelaud
et al., 2011). Infections in these other species of snail may be acci-
dental and may not always lead to the production of cercariae
(Boray, 1969, 1978), but nevertheless other species could represent
additional reservoirs of infection. Accurate identification of these
snails is, therefore, important. Morphological differentiation between
species of the Lymnaeidae family is possible though time consuming
(Bargues & Mas-Coma, 1997) and the internal transcribed spacer
two regions can be used for molecular differentiation (Bargues, Bar-
gues, & Mas-Coma, 2005; Bargues et al., 2001).
Some species of snail may only be susceptible to infection with
F. hepatica as juveniles (Boray, 1978), and it is suggested that this
age-related resistance to infection is related to the maturation of the
snail immune system (Dreyfuss, Abrous, & Rondelaud, 2000). Simi-
larly, differences in susceptibility to F. hepatica infection within pop-
ulations of snails of the same species may be related to variation in
the immune response (Gutierrez, Pointier, Yong, Sanchez, & Theron,
2003; Gutierrez et al., 2003). Further work is required to fully under-
stand why some individual snails produce large numbers of cercariae,
whilst the overall prevalence of infection in snail populations is gen-
erally low.
Infection with F. hepatica can be detected by observing shedding
of cercariae, crushing or microscopic dissection of the snail (Kaplan,
Dame, Reddy, & Courtney, 1995). These methods have poor
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sensitivity in the early stages of infection, and it is difficult to
distinguish the intra-molluscan stages of different species of trema-
todes (Caron, Rondelaud, & Losson, 2008; Heussler, Kaufmann,
Strahm, Liz, & Dobbelaere, 1993; Kaplan et al., 1995). A number of
molecular techniques have been used to detect F. hepatica infection
in snails, which have generally been found to be more sensitive than
microscopic methods (Caron, Lasri, & Losson, 2007; Relf et al.,
2011); however, the presence of inhibitory factors within the snails
can reduce the sensitivity of PCRs (Cucher, Carnevale, Prepelitchi,
Labbe, & Wisnivesky-Colli, 2006) conversely it is important to ensure
that putative trematode-specific PCR primers do not amplify snail
DNA. A number of other trematode species, including those of birds
and amphibians, have been isolated from G. truncatula including Cali-
cophoron daubneyi, Haplometra cylindracea, Notocotylus spp., Pla-
giorchis spp. (Rondelaud, Vignoles, & Dreyfuss, 2015). Some of these
trematodes have little or no published DNA sequence available,
which makes it difficult to ensure PCRs are F. hepatica specific. Fur-
thermore, few of the published F. hepatica PCRs have been validated
for use with snails.
In Europe, the prevalence of F. hepatica infection in G. truncatula
is reported to be around 5% but ranges from 0.5% to 13.5% at dif-
ferent times of year (Mage, Bourgne, Toullieu, Rondelaud, & Drey-
fuss, 2002; Rondelaud & Dreyfuss, 1997; Rondelaud, Vignoles, &
Dreyfuss, 2004; Rondelaud et al., 2015). Most of these studies show
only if a snail is infected, but snails can be infected and not shed
cercariae; in experimental infections the proportion of snails shown
to be infected with F. hepatica but that did not shed cercariae ran-
ged from 12.2% to 67.6% (Dreyfuss, Rondelaud, & Vareille-Morel,
1999; Dreyfuss, Vignoles, Rondelaud, & Vareille-Morel, 1999).
Knowing if a snail can shed cercariae is important to understand its
transmission potential (Ollerenshaw, 1971), but this is difficult to
achieve. Similarly, we know very little about the optimal conditions
required to stimulate shedding of cercariae from snail species other
than G. truncatula (Dreyfuss, Vignoles et al., 1999; El-Shazly, Nabih,
Salem, & Mohamed, 2012). PCRs detect infection with F. hepatica
irrespective of whether snails have, or could shed cercariae and it is
important to highlight the difference between the presence of fluke
DNA in a snail, and the role a particular species has in the epidemiol-
ogy of F. hepatica. For example, the New Zealand mudsnail P. antipo-
darum has been reported to be an intermediate host of F. hepatica
(Jones et al., 2015), yet it has been shown that P. antipodarum feeds
on miracidia rather than becoming infected by them (Nansen, Frand-
sen, & Christensen, 1976). Furthermore, snails can be infected with
more than one species of trematode (Degueurce et al., 1999; Jones
et al., 2015; Rondelaud et al., 2004). One infection is usually domi-
nant over the other (Jones, Brophy, Mitchell, & Williams, 2016; Ron-
delaud, Vignoles, & Dreyfuss, 2007), and therefore, co-infection in
the snail may influence transmission of F. hepatica, but again, this is
a relatively unexplored area of research.
The relatively low pathogenic effect of F. hepatica on the snail
intermediate host means snails can survive for months and produce
cercariae over a prolonged period. Moreover, the rapid clonal expan-
sion that occurs within the snail means the parasite can produce and
shed several hundred cercariae at a time (Boray, 1978; Hodasi,
1972). The time over which snails shed is variable, and shedding is
not continuous. Under experimental conditions a number of factors
can influence the capacity of the snail to produce cercariae, for
example the number of miracidia that infect a snail as well as the
nutrition, age and size of the snail (Belfaiza, Abrous, Rondelaud,
Moncef, & Dreyfuss, 2004; Dreyfuss, Vignoles et al., 1999; Kendall
& Ollerenshaw, 1963; Vignoles, Rondelaud, & Dreyfuss, 2010).
We have shown that parasites with the same genotype tend to
occur in the same animal giving evidence of clumped transmission
and that clonal expansion occurs hence multiple genetically identical
cercariae are likely to be released in a relatively small area (Beesley,
Williams, Paterson, & Hodgkinson, 2017). However, there is little
information on how far snails roam, or the distance cercariae travel
once they exit the snail before encysting. Snails may also be infected
with miracidia of more than one genotype, and shed cercariae of
more than one genotype at the same time. Experimentally snails can
be infected with two miracidia, four hours apart (Dar, Vignoles,
Dreyfuss, & Rondelaud, 2010; Dreyfuss et al., 2000), but it is not
known if this occurs naturally nor if miracidia develop at different
rates, and thus the proportion of genotypes of cercariae that are
released may change overtime. These factors may potentially affect
the distribution of metacercariae on pasture, and thus, the genotypes
of parasites the definitive host is exposed to.
2.1 | Key questions and future directions
For many years, the role of the intermediate host in the Fasciola spp.
life cycle has been relatively neglected, but modern molecular and
genomic tools are becoming available to study events in the snail,
and we can start to address how these impact on transmission and
the spread of virulence and anthelmintic resistance genes within
fluke populations.
3 | EPIDEMIOLOGY
The development of F. hepatica eggs, larval stages and its intermedi-
ate host snails in the environment are highly dependent on geo-cli-
matic, ecological and anthropogenic factors such as elevation,
rainfall, temperature, evapotranspiration, moisture, vegetation and
soil type. As a consequence, F. hepatica is widespread in Europe but
with an uneven spatial distribution and with great regional variations
in prevalence. Recently, European maps of F. hepatica infection risk
in dairy cattle (Ducheyne et al., 2015)and sheep (Rinaldi et al., 2015)
were delivered as product of the EU GLOWORM project. Further-
more, country-specific surveys show herd-level prevalence ranging
from 7% in Sweden to 97% in the alpine upland farms (Charlier, Ver-
cruysse et al., 2014) and from 4.0% in southern Italy to 61.6% in Ire-
land in sheep farms (Rinaldi et al., 2015).
Recent research efforts in the field of F. hepatica epidemiology
have focused on quantifying and understanding the spatial distribu-
tion of F. hepatica, by exploiting the correlations between
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environmental predictors and management factors with livestock’s
exposure to the liver fluke (Bennema et al., 2011; McCann, Baylis, &
Williams, 2010). Recently, the predictive performance of initial statis-
tical models using standard linear or logistic regression analysis has
been outperformed by more advanced modelling approaches such as
random forest and boosted regression trees reaching accuracies of
>95% (Ducheyne et al., 2015; Selemetas et al., 2015). Despite the
important progress in this area, the spatial distribution of F. hepatica
in southern, central and eastern Europe, remains poorly described.
Furthermore, additional research is required to improve the spatial
resolution of F. hepatica risk maps from broad administrative or farm
level to pasture level so that risk maps can support the implementa-
tion of specific management advices on drainage, grazing strategies
and targeted (selective) treatments. Recent studies have explored
the use of very high-resolution satellite and drone imagery to map
small water bodies and the intermediate host snails on pasture, but
further research is required to make this approach operational and
to develop sustainable business cases (Charlier, van der Voort, Ken-
yon, Skuce, & Vercruysse, 2014; Charlier, Soenen et al., 2014; De
Roeck et al., 2014). Enhanced capability to monitor water bodies at
high spatial resolution could be provided by recent sentinel Euro-
pean Space Agency (ESA) satellites, which carry a range of technolo-
gies, such as radar and multi-spectral imaging instruments for land,
ocean and atmospheric observation (https://sentinel.esa.int).
Besides the potential to improve our understanding of the
detailed spatial distribution, research is required to scrutinize the
temporal side of F. hepatica epidemiology. This can be achieved
using both (i) mathematical transmission models and/or forecasting
systems (Baggenstos et al., 2016) and (ii) longitudinal surveys to
monitor evolution in F. hepatica infection over time. Forecasting sys-
tems of autumnal F. hepatica disease risk based on correlations of
temperature and rainfall with disease outbreaks have been available
for a long time in some countries (e.g., in the UK and the Nether-
lands (see (Ollerenshaw & Rowlands, 1959) and (Gaasenbeek, Over,
Noorman, & de Leeuw, 1992)). With ongoing climate change, these
systems have gained renewed interest in the evaluation of its effect
of on the epidemiology of F. hepatica. For instance, (Caminade et al.,
2015) applied climate change scenarios to an existing forecasting
system showing that climate change could lead to significant
increases in infection risk in most parts of Europe, with an extension
of the transmission season of up to 4 months in northern Europe.
However, when applied for short-term prediction of disease occur-
rence, the described forecasting systems are region-specific. They
cannot as such be extrapolated to other regions because they do
not explicitly capture the dependence of the life cycle of F. hepatica
on key environmental factors (Charlier, Soenen et al., 2014). There-
fore, development and validation of mechanistic mathematical mod-
els are required as well as better insights into the effects of
environmental conditions on the survival of eggs, metacercariae and
intermediate host snails on pasture in different geographical settings.
In addition, mechanistic models are not only key to the improved
prediction of F. hepatica disease, but also for the in silico evaluation
of novel control strategies such as vaccination (Turner et al., 2016).
Complementary to predictive systems, it is important to set up
surveillance systems that monitor infection status at farm level on a
regular basis. Such systems can capture unexpected deviations from
mathematical model predictions and indicate whether farmer man-
agement is able to cope with altered disease risk or not. Recently,
Charlier et al. (2016) showed that monitoring F. hepatica-specific
antibody levels in bulk tank milk from a randomized sample of dairy
farms allowed detection of both interannual (weather-driven)
changes as well as longer-term trends in F. hepatica exposure.
Munita et al. (2016) showed that such longitudinal monitoring
approaches can also be an effective decision support tool because it
supported evidence-based interventions leading to year-on-year
reductions in the study farms’ infection status for F. hepatica in Ire-
land. Such monitoring approaches should also take advantage of vet-
erinary or hunting networks for the collection of faecal samples from
non-dairy livestock and wildlife (Mezo et al., 2013; Rinaldi et al.,
2015). The latter is crucial in further elucidating the role of wildlife
for the introduction and the spread of novel (fasciolicide-resistant)
isolates on a farm.
3.1 | Key questions and future directions
Critical questions about the impact of our changing world on fluke
transmission remain. Better national, regional and local forecasting
systems are needed to inform farmers as parasite challenge reaches
its peak and sustainable surveillance systems need to be installed to
validate forecasts and monitor the progress of ongoing control
efforts.
4 | SOCIO-ECONOMICS
Over the last decade, good progress has been made in assessing the
production economic impacts of F. hepatica in ruminants, and these
have extensively been reviewed in sheep (Rojo-Vazquez, Meana,
Valcarcel, & Martınez-Valladares, 2012) and in cattle (Charlier, Ver-
cruysse et al., 2014). A remaining gap is to establish the impact of
F. hepatica on fertility parameters using randomized intervention
field studies. However, the major challenge is to develop tools that
are able to quantify the economic impact of F. hepatica at national,
regional and farm level to support decision-making by governments,
animal health organizations and farmers, respectively and that can be
used as efficient management tools. An example is ParaCalc where
the annual economic impact on a farm is estimated based on farm-
specific diagnostic test results and observed production impacts of
F. hepatica (Charlier, Van der Voort, Hogeveen, & Vercruysse, 2012).
However, this system uses average production estimates as inputs
and thus lacks farm-specificity, and it does not reflect the effect on
the whole-farm economic performance. This is an important gap
because the farmer needs to be able to compare the impact of liver
fluke control with other animal health issues or general interventions
and investment opportunities. Recently, this problem was addressed
by the introduction of efficiency analysis to evaluate the impact of
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helminth infections (van der Voort et al., 2013). Efficiency analysis
studies the conversion of input(s) into output(s) and compares the
current performance level of a farm with the performance level of
peer farms with similar production technologies (Coelli et al., 2005).
A major advantage of efficiency analysis is the possibility of linking
an animal disease or its diagnosis to input allocation, which is at the
core of a farmer’s decision-making process. An efficiency analysis
approach was successfully developed for gastrointestinal nematodes
in cattle (van der Voort, Van Meensel, Lauwers, Van Huylenbroeck,
& Charlier, 2015; van der Voort et al., 2014), and should now be
extended to include other major endemic pathogens including F. hep-
atica. Furthermore, linking such a system to real and actual farm data
is a prerequisite for its success. A closer collaboration between the
model-makers and model-users and the stimulation to develop con-
crete business cases may be the critical success-factor for these sys-
tems to become self-sustainable in the near future.
4.1 | Key questions and future directions
Development of bespoke farm economic models will enable farmers
to make informed choices about what control programmes to adopt
for their enterprise. However, national economic models which
assess the changing disease burden on farm gate, national and inter-
national meat and milk prices are also necessary to feed back into
farm level efficiency analysis.
5 | DIAGNOSIS
Traditionally, fluke infections have been diagnosed by detecting eggs
in faeces (Anderson et al., 1999; Boray, 1985). However, the pre-
patent period is 8–10 weeks depending on the host species; hence,
egg counts are only useful from about 8-week post-infection (wpi)
onwards. In addition, other factors such as host age, faecal water
content and the number of aliquots tested per sample, can all affect
the sensitivity of the faecal egg count (FEC; reviewed by Alvarez
Rojas, Jex, Gasser, and Scheerlinck (2014)). False positives may occur
due to the retention of eggs in the gall bladder for at least 2 weeks
after successful treatment (Flanagan et al., 2011). Coprological sedi-
mentation methods are well established in routine diagnostic labora-
tories, and methods such as FLOTAC (Cringoli, Rinaldi, Maurelli, &
Utzinger, 2010) and Flukefinder (Foreyt, 2001) are available.
Infection can be also confirmed at necropsy and many farmers
use abattoir returns to identify if F. hepatica is present in their live-
stock (Mazeri, Sargison, Kelly, Bronsvoort, & Handel, 2016).
Many immunological techniques have been described that have
higher sensitivity, reproducibility and often cost-effectiveness. Anti-
body detection indirect-enzyme-linked immunosorbent assays
(ELISA) have been developed. Their diagnostic sensitivity and speci-
ficity were reviewed recently by Alvarez Rojas et al. (2014). Most
antibody-detection ELISAs are based on excretory–secretory (E/S)
products, cathepsin L proteinases (CatLs), a group of endopeptidases
secreted in abundant amounts by epithelial cells of immature and
adult Fasciola sp., or a subfraction of the E/S products called F2 anti-
gen. Infection with Fasciola spp. is characterized by an increase in
parasite specific IgG, which is normally detectable by 4 wpi and
reaches a peak between 8 and 10 wpi (Martınez-Perez, Robles-
Perez, Rojo-Vazquez, & Martınez-Valladares, 2014; Salimi-Bejestani
et al., 2005). Whilst antibody-detection tests have excellent sensitiv-
ity, antibodies can remain in serum for several months following suc-
cessful treatment. This makes the interpretation of a positive result
difficult if the full-treatment history is not available.
Antibodies are secreted in milk, meaning that several serum anti-
body tests have been adapted to use either individual or bulk tank
milk samples providing automated, rapid and cheaper methods for
monitoring infection status in dairy herds. Most tests show good
diagnostic sensitivity and specificity and several ELISAs are commer-
cially available for detecting the infection in both milk and serum
samples (Table 1).
Antibody-detection ELISAs are normally developed for a single-
host species due to difficulties in developing good anti-species con-
jugates and typically detect single-parasite species. Ideally, tests that
cover the spectrum of pasture-borne helminthoses, multiple assays
for rapid and high-throughput diagnosis are required. Karanikola
et al. (2015) developed a bead-based assay using fluorescence
detection (xMAP technology) for the simultaneous detection of anti-
bodies against F. hepatica, Cooperia oncophora and Dictyocaulus vivi-
parus in cattle serum samples. This platform was shown to be highly
sensitive and specific in comparison with existing serological and
coprological diagnostic techniques.
Monoclonal antibody-based sandwich ELISAs have been devel-
oped for the detection of circulating antigens in the sera or faeces
from infected animals. A wide range of antigens from F. hepatica
including E/S products, tegumental components, crude extracts from
adult worms and recombinant proteins (such as F. hepatica cathep-
sins, a heat shock protein and a saposin-like protein) has been incor-
porated into antigen detection assays (reviewed by (Alvarez Rojas
et al., 2014)).
The MM3-COPRO test, based on the MM3 MoAb that binds to
both CatL1 and CatL2 proteases (Mezo, Gonzalez-Warleta, Carro, &
Ubeira, 2004), is commercialized by BIO X Diagnostics (La Jemelle,
Belgium). Kajugu et al. (2012, 2015) showed that this test has a high
diagnostic specificity (100%), and showed no cross reaction when
tested with soluble fractions of homogenates from Paramphistomum
TABLE 1 Summary of commercially available antibody-detection
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cervi and Taenia hydatigena but also in co-infections with paramphis-
tome, coccidian and/or gastrointestinal nematodes. However, the
sensitivity of this ELISA can sometimes be compromised by the high
variability in the concentration of cathepsin proteinases in faecal
samples and by differences in the between-batch performance of
peroxidase-labelled anti-mouse IgG polyclonal antibodies (Martınez-
Sernandez, Orbegozo-Medina, Gonzalez-Warleta, Mezo, & Ubeira,
2016). Brockwell, Spithill, Anderson, Grillo, and Sangster (2013) and
Palmer, Lyon, Palmer, and Forshaw (2014) improved the sensitivity
of MM3-COPRO ELISA using a customized cut-off for sheep and
cattle whilst maintaining the specificity above 99%. However, the
test had poor diagnostic sensitivity in horses (Palmer et al., 2014).
Recently a new version of the coproantigen test using a strepta-
vidin-polymerized horseradish peroxidase conjugate was evaluated
and was sufficiently sensitive to detect infection with a single fluke
(Martınez-Sernandez et al., 2016).
Molecular diagnostic methods have been developed to increase
the sensitivity and the specificity of conventional diagnostics.
Martınez-Perez, Robles-Perez, Rojo-Vazquez, and Martınez-Valla-
dares (2012) developed a nested-PCR capable of detecting the infec-
tion in faeces of sheep as early as 2 wpi by amplifying a 423 bp
fragment of the cytochrome C oxidase 1 gene. Robles-Perez,
Martınez-Perez, Rojo-Vazquez, and Martınez-Valladares (2013) also
detected the infection at 2 wpi but by a conventional PCR, which is
a less time consuming method, and amplifying a 292 bp fragment of
the ITS2 gene. Ayaz, Ullah, AbdEl-Salam, Shams, and Niaz (2014)
compared the prevalence of F. hepatica in cattle and buffaloes using
the FEC and a PCR method; authors showed the higher sensitivity
of the molecular technique. Additionally, to differentiate between
species, F. hepatica and F. gigantica, a single-step multiplex PCR was
developed for simultaneous detection using faecal samples (Le et al.,
2012); both species overlap in distribution in some countries of
Africa and Asia and have similar egg morphology, making identifica-
tion from faecal samples difficult.
One of the drawbacks of the PCR is that this technique is only
available in specific laboratories because of the need for specialized
equipment. There are also problems in reproducibility between labora-
tories, with published methods often not working in other diagnostic
laboratories. For these reasons, loop-mediated isothermal amplifica-
tion (LAMP) has been investigated as an alternative to PCR. LAMP
assay is a very specific, efficient and rapid gene amplification proce-
dure in which the reaction can run at a constant temperature (Notomi,
2000). Martınez-Valladares and Rojo-Vazquez (2016) developed a
LAMP assay to detect fluke DNA in faeces of sheep and compared
the results with a conventional PCR. Detection of infection was con-
firmed during the first wpi by both techniques, and in naturally
infected sheep, the sensitivity was slightly higher with the LAMP
assay. In this study, the standard PCR took around 3 hr to obtain a
result, comparing with 1 hr and 10 min for the LAMP assay. However,
Arifin, Hoglund, and Novobilsky (2016), after using the conventional
PCR and LAMP assay in sheep and cattle, found poor sensitivity com-
pared with FEC and sandwich-ELISA techniques. The main reason of
these different results between studies could be due to the DNA
extraction protocols. Indeed, in the study by Martınez-Valladares and
Rojo-Vazquez (2016), samples were subjected to ethanol precipitation
after the DNA extraction, following the protocol described by Robles-
Perez et al. (2013), to concentrate and purify the samples.
With the exception of the LAMP assay, all the diagnostic tests
described for fluke infection require laboratory facilities. This
extends the time taken to get results back to farmers and also
increases cost. Pen-side tests are urgently required by the industry.
The FAMACHA© chart is a low cost tool for determining anaemia
status in ruminants and can be used as part of an integrated worm
control programme. Selective treatment of animals based on anaemic
status is important in preventing anthelmintic resistance (Reynecke,
van Wyk, Gummow, Dorny, & Boomker, 2011). In a study carried
out by Olah, van Wyk, Wall, and Morgan (2015), authors found a
significant correlation between the FAMACHA© score in sheep and
the presence of flukes in the liver (r = .54, p < .001). However, in
cattle naturally infected with F. gigantica and paramphistomes, the
sensitivity and specificity of the FAMACHA© are low (Dorny et al.,
2011; Elelu, Ambali, Coles, & Eisler, 2016).
Martınez-Sernandez et al. (2011) developed a lateral flow test
(SeroFluke) for the serodiagnosis of human fasciolosis. In comparison
with an ELISA test (MM3-SERO), the SeroFluke test showed excel-
lent specificity and sensitivity and could be used with serum or
whole blood samples.
5.1 | Key questions and future directions
Accurate, quick and simple diagnosis of Fasciola spp infection would
allow targeted treatment and more accurate prevalence surveys, but
diagnosis at the moment relies on detection of eggs or F. hepatica-
specific antigen in faeces, or detection of antibody in serum or milk.
All of these assays require some form of laboratory equipment and
results are normally only available to farmers several days after the
sample has been collected All these assays have some limitation, for
example, they only detect patent or historic infection and impor-
tantly, delays in receiving results often means treatments are applied
in the absence of diagnosis of infection. For effective diagnosis of
fluke infection, individual animal diagnostic tests are urgently
required, supported by decision trees to help farmers interpret their
results and administer drugs or implement control programmes effec-
tively. The results presented here, describing lateral flow tests and
other methodologies such as LAMP, show that developing pen-side
tests is feasible and is a research priority. Effective, simple and cost-
effective diagnosis will enable farmers to treat animals in an
informed and targeted manner, and will help the industry move away
from the traditional repeated blanket treatment regimes that have
led to widespread resistance to flukicides.
6 | ANTHELMINTIC RESISTANCE
A number of flukicide drugs are licensed for use in sheep and cattle,
including the benzimidazole derivative triclabendazole (TCBZ),
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albendazole, closantel and clorsulon. Unique amongst these drugs,
TCBZ demonstrates high efficacy against both adult parasites and
immature fluke as early as 2-day post-infection (Boray et al., 1983),
whilst the other flukicides only target flukes from 6- to 14-week
post-infection (Kelley et al., 2016). As a result, TCBZ has become
the drug of choice, particularly for treating acute fasciolosis in sheep,
but this overreliance on TCBZ has inevitably resulted in the emer-
gence of TCBZ-resistance (TCBZ-R) in liver fluke populations. The
threat TCBZ-R poses to the future control of liver fluke infections
was the focus of a recent review which summarizes the number of
cases reported worldwide, since the first report of TCBZ-R in Aus-
tralia in 1995 (Kelley et al., 2016; Overend & Bowen, 1995). To date,
there are 20 peer-reviewed reports of TCBZ-R on sheep farms
within Europe (Table 2), plus a number of anecdotal reports of resis-
tance, which raises the question how prevalent is TCBZ-R in Eur-
ope? It is not clear if reports of drug failure are recorded through
veterinary medicine surveillance schemes and if so, if these data are
available in the public domain? This information is needed to provide
evidence for the widely held belief that resistance is widespread
across Northern Europe and to give a clear picture of the TCBZ-R
status at an individual farm level, to ensure the most effective con-
trol measures are employed.
One of the constraints to determining the full extent of TCBZ-R
is a lack of a quick and reliable diagnostic test to detect resistance in
the field. All the studies shown in Table 2 used the faecal egg count
reduction test (FECRT) method to identify resistance based on a
<95% reduction in egg count 21-day post TCBZ treatment. More
recently the coproantigen reduction test has been favoured but still
requires further validation in field studies (Kelley et al., 2016) and, as
with the FECRT, it is time consuming and lacks the precision to
directly detect drug resistance alleles as they emerge in parasite
populations.
In vitro egg hatch assays have been used to detect resistance to
albendazole and triclabendazole. Albendazole appears to have an ovi-
cidal effect on F. hepatica, and egg hatch assays appear to discrimi-
nate between resistant and susceptible isolates (Canevari et al.,
2013; Novobilsky, Amaya Solis, Skarin, & H€oglund, 2016; Robles-
Perez, Martınez-Perez, Rojo-Vazquez, & Martınez-Valladares, 2014).
In contrast, only one preliminary study suggested that TCBZ had an
ovicidal effect (Fairweather et al., 2012), others showed that an egg
hatch assay was not able to detect resistance to TCBZ in the field
(Robles-Perez, Martınez-Perez, Rojo-Vazquez, & Martınez-Valladares,
2015) and in our experience, the amount of DMSO required to solu-
bilize TCBZ and its metabolites is too toxic, hence if the appropriate
controls are included, the assay cannot discriminate between resis-
tant and susceptible field isolates of F. hepatica (Hodgkinson and
Williams, unpublished observations).
Molecular tools to detect TCBZ-R markers in field samples would
provide precise data with which to target effective treatments and
reduce the potential for TCBZ-R parasites to move from farm to
farm within infected livestock. Development of such a test relies on
knowledge of the mode of action of TCBZ, which despite many
years of study and the proposal of potential drug targets, for exam-
ple, mictrotubule-mediated activity and the adenylate cyclase path-
way, remains unclear. Similarly, the mechanisms of TCBZ-R are not
known, although a number of candidates involved in altered drug
uptake, efflux and/or metabolism have been proposed (Fairweather,
2009). This work has highlighted the importance of distinguishing
between single nucleotide polymorphisms (SNPs) that are inherent in
genetically diverse F. hepatica populations from those SNPs in genes
conferring TCBZ-R and deciphering the differential expression of
proteins responsible for a resistance phenotype rather than those
related to a general stress response (Kelley et al., 2016). These con-
siderations have been the major driver behind a genome-wide
approach to mapping TCBZ-R in genetically recombinant F. hepatica
(Hodgkinson, Cwiklinski, Beesley, Paterson, & Williams, 2013). Our
current lack of understanding of the mechanisms involved in TCBZ-R
raises several questions: Is there a single origin of TCBZ resistance
or multiple origins and is a common pathway involved in the expres-
sion of a TCBZ-R phenotype? Is TCBZ resistance a dominant or
recessive trait? Is the same mechanism employed by both adult para-
sites and newly excysted juveniles (NEJ)? All of which comprise
important knowledge gaps which limit our ability to mitigate the
impact of TCBZ-resistant liver fluke infections.
Alternative chemical options available to target TCBZ-resistant
fluke include treatment with clorsulon, nitroxynil, closantel, albenda-
zole or oxyclozanide (dependent on the host species, (Coles & Staf-
ford, 2001)). Whilst all these chemicals can control TCBZ-resistant
flukes none can kill the juvenile stage of the parasite and therefore
TABLE 2 Published Peer-reviewed Reports of TCBZ-R in Sheep
in Europe (adapted from Kelley et al., 2016)
Year Country or region
Number
of farms Ref
1998 Scotland 1 Mitchell, Maris, & Bonniwell
(1998)





2000 Wales 1 Thomas, Coles, &
Duffus (2000)
2006 Spain 1 Alvarez-Sanchez,
Mainar-Jaime, Perez-Garcia,
& Rojo-Vazquez (2006)
2009 Republic of Ireland 1 Mooney, Good, Hanrahan,
Mulcahy, & de Waal (2009)
2011 Scotland 1 Sargison & Scott (2011)
2012 Wales and Scotland 7 Daniel et al. (2012)
2012 Scotland 2 Gordon, Zadoks, Skuce,
& Sargison (2012)
2015 Northern Ireland 5 Hanna et al. (2015)
Total no. farms on which
reported
20
aReported in cattle as well as sheep.
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have to be used more strategically than TCBZ has historically been
used. Where possible it is important to avoid perceived TCBZ resis-
tance from causing a change in on-farm practice, where farmers rely
heavily on alternative flukicides, such as closantel (McMahon et al.,
2016). This is particularly pertinent given the recent report of the
first case of closantel resistance in cattle in Sweden (Novobilsky &
H€oglund, 2015); which in turn raises the question of how prevalent
is closantel resistance in F. hepatica?
6.1 | Key questions and future directions
If effective drug control is to be implemented, we require knowledge
of the prevalence of flukicide resistance in Europe, in particular to
TCBZ. We need to understand the genetic and molecular basis of
resistance to flukicides in F. hepatica populations, especially to TCBZ
and we require an appreciation of the factors that influence the emer-
gence and spread of drug resistance alleles in liver fluke populations.
7 | IMMUNITY TO FASCIOLA SPP
The immune response to infection of ruminants with F. hepatica and
F. gigantica is often simplified to a simple pattern that is seen during
experimental infection of mice with Schistosoma spp. After an initial
phase of antigen-specific cellular proliferation and IFN-c synthesis
[week 0–2], there is a shift to a Th2/type-2 profile whereby produc-
tion of IL-4 and IL-13 dominates and cellular responses become
more variable and begin to decrease [week 2 – week 6–8] (Clery,
Torgerson, & Mulchaly, 1996; Flynn & Mulcahy, 2008b). As infec-
tions become patent, there is a dramatic collapse in antigen-specific
cellular proliferation and the host cytokine profile becomes domi-
nated by IL-10 and TGF-b. Superimposed on this general description
are multiple waves of eosinophilia, alternative activation of macro-
phages and the progression, from the start of infection onwards,
towards a dominant IgG1 antibody profile (summarized in Fig 1;
(Flynn, Mulcahy, & Elsheikha, 2010)). However, the variety of host
species that can be infected and the differences in the biology of
F. hepatica and F. gigantica make deciphering results and finding
commonalties difficult. Below we summarize immunological findings
with regard to putative mechanisms of protective immunity, and
their initiation and regulation.
7.1 | Parasite recognition and innate effectors
Initial recognition of the metacercariae and NEJs takes place within
the gastrointestinal tract meaning mucosal surveillance, and epithelial
F IGURE 1 Immune responses to Fasciola hepatica; (a) as the life cycle begins within the mammalian host progressing from ingested
metacercariae to NEJ to adult fluke multiple immunological events occur. (b) Alternatively activated macrophages (AAMφ) quickly emerge and
are characterized by arginase-1 and IL-10 expression. These cells have been implicated in examples of host immunomodulation and bystander
suppressive effects shown in (c). In parallel the adaptive response becomes detectable within 3–4 weeks post-infection when both IL-4 and
IgG1 can be measured (e); however, only IgG1 levels are sustained. Simultaneously lymphocyte proliferation (f) is readily detected overlapping
with NEJ presence in the intestine, the peak response is quickly reached and dissipates rapidly. IL-4 (e) and TGF-b (d) are thought to have
T-cell sources during infection and a plateau of TGF-b appears to coincide with IL-4 but only TGF-b levels are maintained. Significantly, IL-10
levels (d) are slower to rise in comparison with TGF-b but remain during experimental infection. IgG1, lymphocyte proliferation and cytokine
responses are correlated with the parasite burden indicating a strong role for antigenic load in driving these responses
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activation is potentially very important. In contrast to murine hel-
minth models, there has been no work to date on the role of the
canonical type 2 cytokines—IL-25, IL-33, TSLP—which have been
shown to be crucial in the development of innate lymphoid cells
(ILC2s) and subsequent CD4 T-cell helper 2 (Th2) responses (Fallon
et al., 2006; Humphreys, Xu, Hepworth, Liew, & Grencis, 2008; Neill
et al., 2010; Oliphant et al., 2014; Taylor et al., 2009). This repre-
sents a major gap in our knowledge and potentially may yet influ-
ence the choice of adjuvants to be used in experimental vaccination
if these cytokines are found to be important in directing the early
host response against the NEJ.
Studies on the recognition of the NEJ have recently benefitted
from the advances made in analysis of proteins and their carbohy-
drate residues. Garcia-Campos et al. (2016) have found that the
tegument of NEJs was primarily composed of oligomannose and
core-fucosylated truncated N-glycans. The importance of these car-
bohydrate residues is re-enforced by the finding that tegumental
antigens (Teg) induce angeric T-cells via dendritic cells (DCs) in a
mannose receptor (MR)-dependent fashion (Aldridge & O’Neill,
2016). A second study from the same group, however, demonstrated
that despite the role of the mannose receptor binding components
in Teg not all of its effects were MR-dependent (Ravida et al., 2016).
Indeed the effects of Teg on DCs are known to TLR4-independent
(Hamilton et al., 2009), while those of excretory/secretory (ES) anti-
gen on the same cell type is partially TLR4-dependent (Dowling
et al., 2010). These results corroborate previous studies, namely that
ES antigens rely partially on both carbohydrates and TLRs to signal
in bovine macrophages (Flynn & Mulcahy, 2008a).
While the recognition of invading NEJs is still under investigation
we now understand that F. hepatica has a profound influence on a
range of innate effector cells. One key mechanism that is becoming
apparent is that host dendritic cells are targeted by a variety of anti-
genic fractions, or specific parasite proteins, that modulate the DC
phenotype to suppress maturation (Dowling et al., 2010; Hamilton
et al., 2009) and generate tolerogenic effects (Falcon et al., 2010)
that were subsequently shown to suppress autoimmunity (Carranza
et al., 2012). Specific mediators of these effects have been described
including a Knutz-like molecule (Falcon et al., 2014)and tegumental
gylcans (Aldridge & O’Neill, 2016). Despite this, there is some sug-
gestion that a component of Fasciola can direct a Th1-like response
through DC instruction and this could result in protection (Falcon,
Carranza, Aoki, Motran, & Cervi, 2011; Noya et al., 2015).
Similar effects have recently been reported in murine mast cells
(Van Milligen, Cornelissen, Hendriks, Gaasenbeek, & Bokhout, 1998;
Vukman et al., 2013), but the functional effect of mast cells has yet
to be definitively shown as there is no evidence they are protective
in rats (Van Milligen et al., 1998) (Van Milligen et al., 1998). Likewise
in bovine infection there is little evidence mast cells increase in num-
ber or % following challenge with F. hepatica (Bossaert, Jacquinet,
Saunders, Farnir, & Losson, 2000; McCole, Doherty, Torgerson, &
Baird, 1998) but in the case of F. gigantica infection of buffaloes his-
tological findings report increased mast cell numbers within the liver
(Molina & Skerratt, 2005). No direct studies have addressed the role
of basophils in Fasciola infection, but there is a brief spike in baso-
phil number in circulation after infection (Poitou, Baeza, & Boulard,
1993). Given that there is a clear role for basophils as major IL-4
secretors in response to protease-type antigens, for example papain,
during the initiation of the CD4 Th2 response (Sokol, Barton, Farr, &
Medzhitov, 2007) and given the abundance of proteases in F. hepat-
ica this is pertinent point for investigation. A study of the human
neutrophil response found that patients with acute disease, har-
boured neutrophils with greater phagocytic function compared to
those in the chronic stage of infection (Osman, Rashwan, & Farag,
1995). Similarly, a study of PMNs from infected goats found that
infected animals had a poor phagocytic response compared to con-
trols and this was also correlated with fluke burdens (Martı́nez-Mor-
eno et al., 2000). A defined role for neutrophils in antibody
dependent cell cytotoxicity (ADCC), or other protective mechanisms,
remains to be demonstrated in fluke-infected cattle.
Eosinophils and macrophages have been shown to mediate
ADCC against F. hepatica in rats (Van Milligen et al., 1998) and
bovine macrophages ex vivo, can kill NEJs (Duffus, Thorne, & Oliver,
1980) although whether this killing is entirely antibody mediated is
questionable (Glauert, Lammas, & Duffus, 1985). Indeed cathepsin
L1 is known to cleave NEJ-bound antibody during this process (Car-
mona, Dowd, Smith, & Dalton, 1993). In cattle and sheep, F. hepatica
induces a liver and blood eosinophilia and F. gigantica infection of
sheep gives the same profile (Chauvin, Moreau, & Boulard, 2001;
Zhang et al., 2005). Paradoxically under the cover of vaccination
calves and goats showing protection had reduced eosinophil counts
(Wedrychowicz et al., 2007; Zafra, Perez-Ecija, Buffoni, Moreno
et al., 2013). This is further complicated by findings using Indonesian
thin tailed (ITT) sheep who display resistance to F. gigantica but not
F. hepatica. (Piedrafita et al., 2007)) demonstrated an ex vivo role for
ADCC by eosinophils in killing F. gigantica but not F. hepatica, how-
ever, (Pleasance, Raadsma et al., 2011) showed that peripheral eosi-
nophilia was not related to resistance to F. gigantica. These findings
raise the prospect that eosinophils act only within the gut or peri-
toneal cavity, but not the liver of some host species in an infection
specific manner. Macrophages have also been shown to mediate
ADCC and again paradoxically a reduction in their alternative activa-
tion profile is also known to be linked to protection in calves during
experimental vaccination (Golden et al., 2010), suggesting that ADCC
mediated by macrophages is nitric oxide mediated, induced in a Th1
cytokine environment and potentially relying on IgG2a. Whether
these effector cells, particularly macrophages and eosinophils, are
targets of F. hepatica immunmodulation, because they are key medi-
ators of protection, has yet to be fully understood.
7.2 | Adaptive responses
The kinetics of B-cells in both infected and vaccinated animals would
suggest that they play a role in providing protection. Chung, Bae,
Yun, Yang, and Kong (2012) noted an accumulation of splenic
CD19+ B-cells post-infection in mice. Zafra et al. (2010) showed an
accumulation of IgG+ cells in the cortex of the hepatic lymph node
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and liver that increased under vaccination. Likewise a similar infiltra-
tion of plasma cells in the livers of water buffalo and cattle is seen
during F. gigantica infection (Molina & Skerratt, 2005). In sheep
infected with F. hepatica there was an 11% increase in the number
of B-cells recruited into ovine hepatic lymph nodes (Meeusen, Lee,
Rickard, & Brandon, 1995). The dynamics of antibody secretion are
relatively straightforward with most experimentally infected animals
seroconverting within 4 weeks of exposure (Flynn & Mulcahy,
2008c). In rats, a general increase in IgG1, IgG2a and IgE was seen
throughout the course of a 10 week infection and only IgM was
noted to decline (Poitou et al., 1993), whereas over a longer period
of time, 7–12 weeks, only IgG1 and IgG2a were found to be main-
tained at levels above baseline (Girones et al., 2007). In cattle, the
balance of isotypes favours IgG1 over IgG2 and in both cattle and
sheep IgG2 is linked with the expression of resistance or protection
against infection (Golden et al., 2010; Pleasance, Wiedosari,
Raadsma, Meeusen, & Piedrafita, 2011). Mechanistically IgG2a is
known to be responsible along with eosinophils in mediating ADCC
in rats (Van Milligen et al., 1998), while in cattle, experimental vacci-
nation achieving protection relies on higher IgG2 (Mulcahy, 1998).
Recently Fu et al. (2016) showed that IL12 and IL18 transcriptions
are inhibited in sheep infected with F. hepatica, leading to changes
in CD40 which are essential to B-cell proliferation and class switch-
ing, suggesting one possible mechanism for the polarization of the
IgG response in infected animals.
Studies of the adaptive cellular response have focused predomi-
nately on CD4 T-cells, but some studies have indicated the presence
of hepatic NK cells in rats producing IFN-c (Tliba, Chauvin, Le Vern,
Boulard, & Sibille, 2002). The antigen-specific recall response is
known to be dominated by IFN-c early in ruminants (Clery et al.,
1996; Flynn & Mulcahy, 2008b) and rodents (O’Neill et al., 2000).
The shift to an IL-4/Th2 dominant response is also known to occur
in cattle and mice, and this is known to be more pronounced in the
mesenteric and hepatic lymph nodes (Flynn & Mulcahy, 2008b; Tliba
et al., 2002). Insights into the chronic state or suppressed cellular
responses have recently seen conflicting findings that Foxp3 is
upregulated (Walsh, Brady, Finlay, Boon, & Mills, 2009)but that aner-
gic T-cells, characterized by PD-1, might have a bigger role to play.
Recent evidence in ruminants suggest that cd T-cells, not CD4 T-
cells, are the major expresser of Foxp3 (Guzman et al., 2014)and that
immune checkpoint molecules such as PD-1, CTLA-4 and LAG1
might have greater roles to play in non-responsive CD4 T-cells dur-
ing chronic infection (Ikebuchi et al., 2014). What has become appar-
ent from a number of recent transcriptomic studies is that the il12,
tnf, and ifng complex is downregulated in ovine PBMCs as infection
progresses (Fu et al., 2016), whilst within the liver, genes mediating
Th2 cellular responses were upregulated (Alvarez Rojas et al., 2014).
7.2.1 | Key questions and future directions
While great progress has been made in recent years much is yet to
be understood about the fundamental nature of the host-parasite
relationship and a number of areas need to be addressed. Firstly, the
vast bulk of our knowledge draws on experimental infections; well-
controlled experiments studying the dynamics of host immunity in
field conditions are desperately needed. These will help to validate
or discount experimental data and also provide vital baseline infor-
mation to feed into vaccination trials. The interpretation of these
field data will need to be approached cautiously to carefully model
the vastly more confounding variables influencing such experiments.
Secondly, what role do the canonical type-2 cytokines have on the
initiation of the immune response? The consensus from murine mod-
els of infection would suggest that these cytokines in conjunction
with the cells they elicit, the ILC2s, are pivotal in orchestrating
immunity. Finally, determining the mechanisms of parasite killing is
key to developing effective vaccines. Clearly there is a role for
ADCC; however, the site of its action and the host cells involved
remain to be further elucidated.
8 | VACCINE DEVELOPMENT
The current control of F. hepatica relies primarily on the use of
anthelmintic drugs. In view of a changing climate, increasing preva-
lence of infection and resistance to the limited number of flukicides
available, there is an urgent need for alternative control methods.
During the last two decades, vaccines have been considered a
promising and economically viable alternative strategy for the control
of fasciolosis in livestock (McManus & Dalton, 2006; Molina-Hernan-
dez et al., 2015; Toet, Piedrafita, & Spithill, 2014; Yap & Smooker,
2016). Fluke vaccine studies have been conducted in laboratory ani-
mals such as rats, mice and rabbits (reviewed by (Meemon & Sob-
hon, 2016)) and in ruminants (cattle, sheep and goats). Vaccine trials
in rodent models are much cheaper than conducting trials in rumi-
nants, and they are useful to study the mechanism of the immune
response in protected and non-protected animals, but the levels of
protection recorded in animal models, particularly in the rat, are diffi-
cult to replicate in livestock species.
A crucial question for a successful commercial fluke vaccine is
the level of protection required to increase livestock production. As
production losses are observed in sheep showing 30–54 flukes (Dar-
gie, 1987), in herds with low and high fluke burdens a protection of
50% and 80%, respectively, would be sufficient (Toet et al., 2014).
Recent modelling studies have reported that a vaccine inducing a
reduction in fluke burden of 43%, but which protects 90% of the
herd and lasts for a full season, would have an important impact on
the control of disease (Turner et al., 2016). Many prototype vacci-
nes, although they have a variable effect on fluke burden, have a sig-
nificant effect on egg output and egg viability. Hence more attention
is needed to evaluate these effects in vaccine trials. As F. hepatica
causes important hepatic damage in sheep, particularly during the
migratory phase, even without significant fluke reduction some trial
vaccines induced less hepatic damage and higher weight gain than
unvaccinated controls (Zafra, Perez-Ecija, Buffoni, Pacheco et al.,
2013). This suggests that reduction hepatic damage will have an
impact in reducing production losses.
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A better understanding of the mechanism of the protective
response against Fasciola spp in ruminants is vital to fully understand
how best to develop and deliver vaccines (Molina-Hernandez et al.,
2015). In vaccinated cattle, a Th1 response with high titres of IgG2
and low titres of IgG1 has been correlated with protection (Mulcahy
et al., 1999). More recent trials in cattle (Golden et al., 2010), sheep
(Maggioli et al., 2011)and goats (Villa-Mancera, Reynoso-Palomar,
Utrera-Quintana, & Carreon-Luna, 2013) found high levels of IgG2
and IgG1 associated with protection, possibly indicating a mixed
Th1/Th2 response. As described in Section 7, Fasciola spp. has the
capacity to modulate the host response facilitating parasite survival
during both acute and chronic stages of infection. Alternative activa-
tion of macrophages, a skewed Th2 response and expansion of regu-
latory T cells and apoptosis of effector cells (Dalton, Robinson,
Mulcahy, O’Neill, & Donnelly, 2013; Escamilla, Bautista et al., 2016;
Escamilla, Zafra et al., 2016; Fu et al., 2016) have been reported in
laboratory animals and ruminants. Cathepsins (CL), peroxiredoxin
(Prx) and helminth defence molecules (HDM) are thought to be
involved in several immunomodulatory mechanisms (Dalton et al.,
2013). The inclusion of immunomodulatory molecules in vaccines
formulated with appropriate adjuvants to enhance Th1 responses
may help to reduce the effects of parasite immunomodulation thus
increasing vaccine efficacy. A protective host response has been
described in the early stages of infection affecting the peritoneal or
early hepatic migratory stages of the parasite; however, recent vac-
cine trials against F. hepatica in rats have reported that, at least in
part, protective responses occur in the biliary compartment (Weso-
łowska et al., 2017). These are interesting data as an effective
response against mature flukes would lower egg output and egg via-
bility, which in turn, would reduce transmission.
The duration of protective immunity is important for the com-
mercial success of a vaccine, but little information on the longevity
of the protective response is available from experimental trials. Mod-
elling studies have shown that protection that lasts a whole grazing
season is required for a vaccine to be commercially viable (Turner
et al., 2016). The age of protected animals is also relevant as lambs
and calves are put out onto pasture between one and 2 months of
age. Hence for a vaccine to be viable, it should be effective in young
animals as well as older stock and to date most of vaccine trials have
been focused on sheep and cattle with more than 4 months of age.
A variety of native purified antigens have been used in vaccine
trials in cattle and sheep, including native fatty acid binding proteins
(FABP) induced 55% protection in cattle against F. hepatica; native
cathepsin L1 (CL1) induced 42%–69% protection in cattle and 34%
protection in sheep; native glutathione S transferase (GST) induced
57% worm reduction in sheep and 0%–69% protection in cattle.
Native leucine aminopeptidase (LAP) induced 89% protection in
sheep (reviewed by (Toet et al., 2014; Yap & Smooker, 2016)). As
native fluke antigens are not viable for a commercial vaccine,
research has focused on developing individual recombinant antigens.
However, numerous trials have shown no significant or discrete pro-
tection (Toet et al., 2014; Yap & Smooker, 2016). Some trials using
recombinant antigens have shown very high protection, for example,
a trial using recombinant Schistosoma mansoni 14 antigen (rSm14) in
RIBI adjuvant, induced 98.5% protection in (Almeida et al., 2003),
although the groups were small (n = 4), and protection was not con-
firmed in subsequent trials in goats (Mendes et al., 2010). A second
study used rLAP from F. hepatica given in different adjuvants in
sheep, and led to a reduction in fluke burden of 74% and 86% with
adjuvac 50 and alum adjuvant, respectively (Maggioli et al., 2011).
Using CL1/CL2 mimitopes, Villa-Mancera et al. (2008) reported 47%
protection in sheep, and CL1 mimitopes on their own led to protec-
tion of 51% in sheep (Villa-Mancera & Mendez-Mendoza, 2012) and
46%–79% in goats (Villa-Mancera et al., 2013). These promising
results in sheep and goats have yet to be validated in subsequent
trials and in field trials.
As for several other helminth vaccines, it is recognized that fluke
vaccines based on single molecules are probably unrealistic, hence
different antigen combinations have been evaluated. To date, most
combinations have been based on native rather than recombinant
antigens, for example, CL1+ Haemoglobin (Hb), CL2+ Hb and CL1+
CL2. With these combinations, protection ranged from 0% in sheep
to 72% in cattle (Dalton, McGonigle, Rolph, & Andrews, 1996; Mulc-
ahy et al., 1999) whilst native CL1+ CL2+ LAP induced a reduction
of 79% in worm burden in sheep (Piacenza, Acosta, Basmadjian, &
Carmona, 1998). More recent studies using recombinant proteins
showed promising results: in cattle immunized with recombinant
cathepsin L1 (CL1) a significant reduction in fluke burden of 48%
was found (Golden et al., 2010); and in buffalo, recombinant FABP
and GST induced a 35% reduction in F. gigantica (Kumar et al.,
2011). A combination of several immunomodulatory and biologically
relevant parasite molecules with the appropriate adjuvant and/or
delivery system to drive a Th1 or a mixed Th1/Th2 response may
enhance vaccine protection. Antigen competition should also be
taken into account when using vaccines with multiple antigen combi-
nations.
8.1 | Key questions and future directions
The significant levels of protection, in terms of a reduction in fluke
burden, faecal egg output and egg viability found in trials using com-
binations of antigens, in cattle, sheep and goats, suggest a fluke vac-
cine is a feasible and viable method for the control of fasciolosis in
livestock that will lessen anthelmintic use and slow the spread resis-
tance. Nevertheless, much more work is needed to: (i) confirm the
reproducibility of those trials under both experimental and field con-
ditions; (ii) improve our understanding of protective and non-protec-
tive immune mechanisms in ruminants and identify those parasite
molecules involved in immunomodulation; (iii) investigate with the
most appropriate antigen/adjuvant combinations for sheep and cattle
to improve vaccine efficacy; (iv) better understand the duration of
immunity, how animal age affects vaccine success and to quantify
the effect of reduced egg number and viability on transmission of
the parasite.
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Liver fluke is a common parasite that affects the productivity and
welfare of cattle and sheep. Control is confounded by the lack of
low cost, accurate, animal-side diagnostics, issues surrounding use of
drugs in milking cattle, anthelmintic resistance and climate change
that will significantly alter the epidemiology and transmission of the
parasite over the coming decades. Research is urgently needed into
many areas of fluke biology, and control that this review has sought
to highlight. The availability of an annotated, whole-genome map of
F. hepatica (Cwiklinski et al., 2015) will accelerate developments in
many of these areas. Better advice on control of the parasite at the
farm level is also imperative and will depend on our growing under-
standing of the complex interactions between environment, ecosys-
tems, snail host, wildlife hosts and farmed animals.
ACKNOWLEDGEMENTS
All authors are members of the Livestock Helminth Research Alliance
(LiHRA), whose vision is to improve the health, wealth and produc-
tivity of European livestock by providing sustainable helminth control
options. This review was commissioned by DISCONTOOLS (www.d
iscontools.eu) as part of the process of identifying research gaps
which impinge on effective and sustainable control of fasciolosis
in food producing animals in Europe. DJLW, JC, LR, CC, JPA, AMM
all received funding from the European Union through the following
awards: FPVI-FOOD-CT-200X-023025-DELIVER; FPVII-KBBE-2011-
5-288975-GLOWORM; FPVII-KBBE-2010-4-265862-PARAVAC; H2020-
635408-PARAGONE. DJLW, JEH, NJB received funding from the
Biotechnology and Biological Sciences Research Council (BBSRC)
through awards: BB/K015591/1 and BBI002480/1, and RJF was
supported by BBSRC award BB/M018520/1. MMV was funded by
the Spanish “Ramon y Cajal” Programme of the Ministry of Economy
and Competitiveness (RYC-2015-18368). CC was funded by the
National Institute for Health Research Health Protection Research
Unit (NIHR HPRU) in Emerging and Zoonotic Infections at the
University of Liverpool in partnership with Public Health England
(PHE) and Liverpool School of Tropical Medicine (LSTM). The views
expressed are those of the author(s) and not necessarily those of the
NHS, the NIHR, the Department of Health or PHE.
REFERENCES
Abrous, M., Rondelaud, D., Dreyfuss, G., & Cabaret, J. (1999). Infection
of Lymnaea truncatula and Lymnaea glabra by Fasciola hepatica and
Paramphistomum daubneyi in farms of central France. Veterinary
Research, 30, 113–118.
Aldridge, A., & O’Neill, S. M. (2016). Fasciola hepatica tegumental anti-
gens induce anergic-like T cells via dendritic cells in a mannose
receptor-dependent manner. European Journal of Immunology, 46,
1180–1192.
Almeida, M. S., Torloni, H., Lee-Ho, P., Vilar, M. M., Thaumaturgo, N.,
Simpson, A. J., & Tendler, M. (2003). Vaccination against Fasciola hep-
atica infection using a Schistosoma mansoni defined recombinant anti-
gen, Sm14. Parasite Immunology, 25, 135–137.
Alvarez Rojas, C. A., Jex, A. R., Gasser, R. B., & Scheerlinck, J. P. (2014).
Techniques for the diagnosis of Fasciola infections in animals: Room
for improvement. Advances in Parasitology, 85, 65–107.
Alvarez-Sanchez, M. A., Mainar-Jaime, R. C., Perez-Garcia, J., & Rojo-Vaz-
quez, F. A. (2006). Resistance of Fasciola hepatica to triclabendazole
and albendazole in sheep in Spain. Veterinary Record, 159, 424–425.
Anderson, N., Luong, T. T., Vo, N. G., Bui, K. L., Smooker, P. M., & Spithill,
T. W. (1999). The sensitivity and specificity of two methods for
detecting Fasciola infections in cattle. Veterinary Parasitology, 83, 15–
24.
Arifin, M. I., Hoglund, J., & Novobilsky, A. (2016). Comparison of molecu-
lar and conventional methods for the diagnosis of Fasciola hepatica
infection in the field. Veterinary Parasitology, 232, 8–11.
Armour, J. (1975). The epidemiology and control of bovine fascioliasis.
Veterinary Record, 96, 198–201.
Ayaz, S., Ullah, R., AbdEl-Salam, N. M., Shams, S., & Niaz, S. (2014). Fasci-
ola hepatica in some Buffaloes and cattle by PCR and microscopy.
The Scientific World Journal, 2014, 462084.
Baggenstos, R., Dahinden, T., Torgerson, P. R., B€ar, H., Rapsch, C., &
Knubben-Schweizer, G. (2016). Validation of an interactive map
assessing the potential spread of Galba truncatula as intermediate
host of Fasciola hepatica in Switzerland. Geospatial Health, 11, doi:
10.4081/gh.2016.418.
Bargues, M. D., Bargues, M. D., & Mas-Coma, S. (2005). Reviewing lym-
naeid vectors of fascioliasis by ribosomal DNA sequence analyses.
Journal of Helminthology, 79, 257–267.
Bargues, M. D., & Mas-Coma, S. (1997). Phylogenetic analysis of Lym-
naeid snails based on 18S rDNA sequences. Molecular Biology and
Evolution, 14, 569–577.
Bargues, M. D., Vigo, M., Horak, P., Dvorak, J., Patzner, R. A., Pointier, J.
P., . . . Mas-Coma, S. (2001). European Lymnaeidae (Mollusca: Gas-
tropoda), intermediate hosts of trematodiases, based on nuclear ribo-
somal DNA ITS-2 sequences. Infection, Genetics and Evolution, 1, 85–
107.
Beesley, N. J., Williams, D. J. L., Paterson, S., & Hodgkinson, J. (2017).
Fasciola hepatica demonstrates high levels of genetic diversity, a lack
of population structure and high gene flow: Possible implications for
drug resistance. International Journal for Parasitology, 47, 11–20.
Belfaiza, M., Abrous, M., Rondelaud, D., Moncef, M., & Dreyfuss, G.
(2004). The use of Tetraphyll as food for snails increases the intensity
of cercarial shedding in Galba truncatula infected with Fasciola hepat-
ica. Parasitology Research, 94, 86–90.
Bennema, S. C., Ducheyne, E., Vercruysse, J., Claerebout, E., Hendrickx,
G., & Charlier, J. (2011). Relative importance of management, meteo-
rological and environmental factors in the spatial distribution of Fasci-
ola hepatica in dairy cattle in a temperate climate zone. International
Journal for Parasitology, 41, 225–233.
Boray, J. C. (1969). Experimental fascioliasis in Australia. Advances in Par-
asitology, 7, 95–210.
Boray, J. C. (1978). The potential impact of exotic Lymnaea spp. on fasci-
oliasis in Australasia. Veterinary Parasitology, 4, 127–141.
Boray, J. C. (1985). Flukes of domestic animals. In S. M. Gaafar, W. E.
Howard, & R. E. Marsh (Eds.), Parasites, pests and predators (pp. 179–
218). New York: Elsevier.
Boray, J., Crowfoot, P., Strong, M., Allison, J., Schellenbaum, M., Von
Orelli, M., & Sarasin, G. (1983). Treatment of immature and mature
Fasciola hepatica infections in sheep with triclabendazole. Veterinary
Record, 113, 315–317.
Bossaert, K., Jacquinet, E., Saunders, J., Farnir, F., & Losson, B. (2000).
Cell-mediated immune response in calves to single-dose, trickle, and
challenge infections with Fasciola hepatica. Veterinary Parasitology, 88,
17–34.
Brockwell, Y. M., Spithill, T. W., Anderson, G. R., Grillo, V., & Sangster, N.
C. (2013). Comparative kinetics of serological and coproantigen ELISA
and faecal egg count in cattle experimentally infected with Fasciola
12 | BEESLEY ET AL.
hepatica and following treatment with triclabendazole. Veterinary Par-
asitology, 196, 417–426.
Caminade, C., Van Dijk, J., Baylis, M., & Williams, D. (2015). Modelling
recent and future climatic suitability for fasciolosis in Europe. Geospa-
tial Health, 9, 301.
Ca~nete, R., Yong, M., Sanchez, J., Wong, L., & Gutierrez, A. (2004). Popu-
lation dynamics of intermediate snail hosts of Fasciola hepatica and
some environmental factors in San Juan y Martinez municipality,
Cuba. Memorias do Instituto Oswaldo Cruz, 99, 257–262.
Canevari, J., Ceballos, L., Sanabria, R., Romero, J., Olaechea, F., Ortiz, P.,
. . . Alvarez, L. (2013). Testing albendazole resistance in Fasciola hep-
atica: Validation of an egg hatch test with isolates from South Amer-
ica and the United Kingdom. Journal of Helminthology, 88, 286–292.
Carmona, C., Dowd, A. J., Smith, A. M., & Dalton, J. P. (1993). Cathepsin
L proteinase secreted by Fasciola hepatica in vitro prevents antibody-
mediated eosinophil attachment to newly excysted juveniles. Molecu-
lar and Biochemical Parasitology, 62, 9–17.
Caron, Y., Lasri, S., & Losson, B. (2007). Fasciola hepatica: An assessment
on the vectorial capacity of Radix labiata and R. balthica commonly
found in Belgium. Veterinary Parasitology, 149, 95–103.
Caron, Y., Martens, K., Lempereur, L., Saegerman, C., & Losson, B. (2014).
New insight in lymnaeid snails (Mollusca, Gastropoda) as intermediate
hosts of Fasciola hepatica (Trematoda, Digenea) in Belgium and Lux-
embourg. Parasites & Vectors, 7, 66.
Caron, Y., Rondelaud, D., & Losson, B. (2008). The detection and quan-
tification of a digenean infection in the snail host with special empha-
sis on Fasciola sp. Parasitology Research, 103, 735–744.
Carranza, F., Falcon, C. R., Nu~nez, N., Knubel, C., Correa, S. G., Bianco, I.,
. . . Cervi, L. (2012). Helminth antigens enable CpG-activated dendritic
cells to inhibit the symptoms of collagen-induced arthritis through
Foxp3+ regulatory T cells. PLoS One, 7, e40356.
Charlier, J., Bennema, S. C., Caron, Y., Counotte, M., Ducheyne, E., Hen-
drickx, G., & Vercruysse, J. (2011). Towards assessing fine-scale indi-
cators for the spatial transmission risk of Fasciola hepatica in cattle.
Geospatial Health, 5, 239.
Charlier, J., Duchateau, L., Claerebout, E., Williams, D., & Vercruysse, J.
(2007). Associations between anti-Fasciola hepatica antibody levels in
bulk-tank milk samples and production parameters in dairy herds.
Preventive Veterinary Medicine, 78, 57–66.
Charlier, J., Ghebretinsae, A. H., Levecke, B., Ducheyne, E., Claerebout,
E., & Vercruysse, J. (2016). Climate-driven longitudinal trends in pas-
ture-borne helminth infections of dairy cattle. International Journal for
Parasitology, 46, 881–888.
Charlier, J., Soenen, K., De Roeck, E., Hantson, W., Ducheyne, E., Van
Coillie, F., . . . Vercruysse, J. (2014). Longitudinal study on the tempo-
ral and micro-spatial distribution of Galba truncatula in four farms in
Belgium as a base for small-scale risk mapping of Fasciola hepatica.
Parasites & Vectors, 7, 528.
Charlier, J., Van der Voort, M., Hogeveen, H., & Vercruysse, J. (2012).
ParaCalc—A novel tool to evaluate the economic importance of
worm infections on the dairy farm. Veterinary Parasitology, 184, 204–
211.
Charlier, J., van der Voort, M., Kenyon, F., Skuce, P., & Vercruysse, J.
(2014). Chasing helminths and their economic impact on farmed
ruminants. Trends in Parasitology, 30, 361–367.
Charlier, J., Vercruysse, J., Morgan, E., van Dijk, J., & Williams, D. J.
(2014). Recent advances in the diagnosis, impact on production and
prediction of Fasciola hepatica in cattle. Parasitology, 141, 326–335.
Chauvin, A., Moreau, E., & Boulard, C. (2001). Responses of Fasciola hep-
atica infected sheep to various infection levels. Veterinary Research,
32, 87–92.
Chung, J.-Y., Bae, Y.-A., Yun, D.-H., Yang, H.-J., & Kong, Y. (2012). Exper-
imental murine fascioliasis derives early immune suppression with
increased levels of TGF-b and IL-4. Korean Journal of Parasitology, 50,
301–308.
Claridge, J., Diggle, P., McCann, C. M., Mulcahy, G., Flynn, R., McNair, J.,
. . . Williams, D. J. L. (2012). Fasciola hepatica is associated with the
failure to detect bovine tuberculosis in dairy cattle. Nature Communi-
cations, 3, 853.
Clery, D., Torgerson, P., & Mulchaly, G. (1996). Corrigendum to “Immune
responses of chronically infected adult cattle to Fasciola hepatica”
[Vet. Parasitol., 62 (1996) 71–82]. Veterinary Parasitology, 65, 169.
Coelli, T. J., D. S. P. Rao, C. J. O’Donnell, and G. E. Battese, 2005. An
introduction to efficiency and productive analysis. Springer, New
York, NY. 349 pp.
Coles, G. C., & Stafford, K. A. (2001). Activity of oxyclozzanide, nitroxynil,
clorsulon and albendazole against adult triclabendazole resistant Fas-
ciola hepatica. Veterinary Record, 148, 723–724.
Cringoli, G., Rinaldi, L., Maurelli, M. P., & Utzinger, J. (2010). FLOTAC:
New multivalent techniques for qualitative and quantitative copromi-
croscopic diagnosis of parasites in animals and humans. Nature Proto-
cols, 5, 503–515.
Crossland, N. (1976). The effect of the molluscicide N-tritylmorpholine
on transmission of Fasciola hepatica. Veterinary Record, 98, 45–48.
Cucher, M. A., Carnevale, S., Prepelitchi, L., Labbe, J. H., & Wisnivesky-
Colli, C. (2006). PCR diagnosis of Fasciola hepatica in field-collected
Lymnaea columella and Lymnaea viatrix snails. Veterinary Parasitology,
137, 74–82.
Cwiklinski, K., Dalton, J. P., Dufresne, P. J., La Course, J., Williams, D. J.
L., Hodgkinson, J., & Paterson, S. (2015). The Fasciola hepatica gen-
ome: Gene duplication and polymorphism reveals adaptation to the
host environment and the capacity for rapid evolution. Genome Biol-
ogy, 16, 71–84.
Dalton, J. P. (1999). Fasciolosis. Wallingford: CABI Pub.
Dalton, J. P., McGonigle, S., Rolph, T. P., & Andrews, S. J. (1996). Induc-
tion of protective immunity in cattle against infection with Fasciola
hepatica by vaccination with cathepsin L proteinases and with hemo-
globin. Infection and Immunity, 64, 5066–5074.
Dalton, J. P., Robinson, M. W., Mulcahy, G., O’Neill, S. M., & Donnelly, S.
(2013). Immunomodulatory molecules of Fasciola hepatica: Candidates
for both vaccine and immunotherapeutic development. Veterinary
Parasitology, 195, 272–285.
Daniel, R., van Dijk, J., Jenkins, T., Akca, A., Mearns, R., & Williams, D. J.
L. (2012). Composite faecal egg count reduction test to detect resis-
tance to triclabendazole in Fasciola hepatica. Veterinary Record, 171,
153–153.
Dar, Y., Vignoles, P., Dreyfuss, G., & Rondelaud, D. (2010). The develop-
ment of rediae of Fasciola hepatica in Radix natalensis subjected twice
to bimiracidial exposures. Journal of Helminthology, 85, 210–214.
Dargie, J. D. (1987). The impact on production and mechanisms of patho-
genesis of trematode infections in cattle and sheep. International
Journal for Parasitology, 17, 453–463.
Degueurce, F., M. Abrous, G. Dreyfuss, D. Rondelaud, and J. Gevrey,
1999: Paramphistomum daubneyi and Fasciola hepatica: the preva-
lence of natural or experimental infections in four species of fresh-
water snails in eastern France. Journal of Helminthology 73, 197–202.
De Roeck, E., Van Coillie, F., De Wulf, R., Soenen, K., Charlier, J., Ver-
cruysse, J., . . . Hendrickx, G. (2014). Fine-scale mapping of vector
habitats using very high resolution satellite imagery: A liver fluke
case-study. Geospatial Health, 8, 671.
Dorny, P., Stoliaroff, V., Charlier, J., Meas, S., Sorn, S., Chea, B., . . .
Vercruysse, J. (2011). Infections with gastrointestinal nematodes,
Fasciola and Paramphistomum in cattle in Cambodia and their asso-
ciation with morbidity parameters. Veterinary Parasitology, 175,
293–299.
Dowling, D. J., Hamilton, C. M., Donnelly, S., La Course, J., Brophy, P. M.,
Dalton, J., & O’Neill, S. M. (2010). Major secretory antigens of the
helminth Fasciola hepatica activate a suppressive dendritic cell pheno-
type that attenuates Th17 cells but fails to activate Th2 immune
responses. Infection and Immunity, 78, 793–801.
BEESLEY ET AL. | 13
Dreyfuss, G., Abrous, M., & Rondelaud, D. (2000). The susceptibility of
Lymnaea fuscus to experimental infection with Fasciola hepatica. Jour-
nal of Parasitology, 86, 158.
Dreyfuss, G., Alarion, N., Vignoles, P., & Rondelaud, D. (2005). A retro-
spective study on the metacercarial production of Fasciola hepatica
from experimentally infected Galba truncatula in central France. Para-
sitology Research, 98, 162–166.
Dreyfuss, G., Rondelaud, D., & Vareille-Morel, C. (1999). Oviposition of
Lymnaea truncatula infected by Fasciola hepatica under sexperimental
conditions. Parasitology Research, 85, 589–593.
Dreyfuss, G., Vignoles, P., Rondelaud, D., & Vareille-Morel, C. (1999). Fas-
ciola hepatica: Characteristics of infection in Lymnaea truncatulain
relation to the number of Miracidia at exposure. Experimental Para-
sitology, 92, 19–23.
Ducheyne, E., Charlier, J., Vercruysse, J., Rinaldi, L., Biggeri, A., Demeler,
J., . . . Hendrickx, G. (2015). Modelling the spatial distribution of Fasci-
ola hepatica in dairy cattle in Europe. Geospatial Health, 9, 261.
Duffus, W. P., Thorne, K., & Oliver, R. (1980). Killing of juvenile Fasciola
hepatica by purified bovine eosinophil proteins. Clinical and Experi-
mental Immunology, 40, 336–344.
Elelu, N., Ambali, A., Coles, G. C., & Eisler, M. C. (2016). Cross-sectional
study of Fasciola gigantica and other trematode infections of cattle in
Edu Local Government Area, Kwara State, north-central Nigeria. Par-
asites & Vectors, 9, 470–480.
El-Shazly, A. M., Nabih, N., Salem, D. A.-B., & Mohamed, M. Z. (2012).
Snail populations in Dakahlia Governorate, Egypt, with special refer-
ence to lymnaeids. Egypt Journal of Biology, 14, 45–49.
Escamilla, A., Bautista, M. J., Zafra, R., Pacheco, I. L., Ruiz, M. T.,
Martınez-Cruz, S., . . . Perez, J. (2016). Fasciola hepatica induces eosi-
nophil apoptosis in the migratory and biliary stages of infection in
sheep. Veterinary Parasitology, 216, 84–88.
Escamilla, A., Zafra, R., Perez, J., McNeilly, T. N., Pacheco, I. L., Buf-
foni, L., . . . Martinez-Moreno, A. (2016). Distribution of Foxp3+ T
cells in the liver and hepatic lymph nodes of goats and sheep
experimentally infected with Fasciola hepatica. Veterinary Parasitol-
ogy, 230, 14–19.
Fairweather, I. (2009). Triclabendazole progress report, 2005–2009: An
advancement of learning? Journal of Helminthology, 83, 139.
Fairweather, I., McShane, D. D., Shaw, L., Ellison, S. E., O’Hagan, N. T.,
York, E. A., . . . Brennan, G. P. (2012). Development of an egg hatch
assay for the diagnosis of triclabendazole resistance in Fasciola hepat-
ica: Proof of concept. Veterinary Parasitology, 183, 249–259.
Falcon, C. R., Carranza, F. A., Aoki, P., Motran, C. C., & Cervi, L. (2011).
Adoptive transfer of dendritic cells pulsed with Fasciola hepatica anti-
gens and lipopolysaccharides confers protection against fasciolosis in
mice. Journal of Infectious Diseases, 205, 506–514.
Falcon, C., Carranza, F., Martinez, F. F., Knubel, C. P., Masih, D. T.,
Motran, C. C., & Cervi, L. (2010). Excretory-secretory products (ESP)
from Fasciola hepatica induce tolerogenic properties in myeloid den-
dritic cells. Veterinary Immunology and Immunopathology, 137, 36–46.
Falcon, C. R., Masih, D., Gatti, G., Sanchez, M. C., Motran, C. C., & Cervi,
L. (2014). Fasciola hepatica Kunitz type molecule decreases dendritic
cell activation and their ability to induce inflammatory responses.
PLoS One, 9, e114505.
Fallon, P. G., Ballantyne, S. J., Mangan, N. E., Barlow, J. L., Dasvarma, A.,
Hewett, D. R., . . . McKenzie, A. N. J. (2006). Identification of an
interleukin (IL)-25–dependent cell population that provides IL-4, IL-5,
and IL-13 at the onset of helminth expulsion. Journal of Experimental
Medicine, 203, 1105–1116.
Flanagan, A., Edgar, H. W. J., Gordon, A., Hanna, R. E. B., Brennan, G. P.,
& Fairweather, I. (2011). Comparison of two assays, a faecal egg
count reduction test (FECRT) and a coproantigen reduction test
(CRT), for the diagnosis of resistance to triclabendazole in Fasciola
hepatica in sheep. Veterinary Parasitology, 176, 170–176.
Flynn, R. J., & Mulcahy, G. (2008a). Possible role for Toll-like receptors in
interaction of Fasciola hepatica excretory/secretory products with
bovine macrophages. Infection and Immunity, 76, 678–684.
Flynn, R. J., & Mulcahy, G. (2008b). The roles of IL-10 and TGF-beta in
controlling IL-4 and IFN-gamma production during experimental Fas-
ciola hepatica infection. International Journal for Parasitology, 38,
1673–1680.
Flynn, R. J., & Mulcahy, G. (2008c). The roles of IL-10 and TGF-b in con-
trolling IL-4 and IFN-c production during experimental Fasciola hepat-
ica infection. International Journal for Parasitology, 38, 1673–1680.
Flynn, R. J., Mulcahy, G., & Elsheikha, H. M. (2010). Coordinating innate
and adaptive immunity in Fasciola hepatica infection: Implications for
control. Veterinary Parasitology, 169, 235–240.
Foreyt, W. J. (2001). Veterinary parasitology reference manual. Ames, IA:
Iowa State University Press; London: Eurospan.
Fu, Y., Chryssafidis, A. L., Browne, J. A., O’Sullivan, J., McGettigan, P. A.,
& Mulcahy, G. (2016). Transcriptomic study on ovine immune
responses to Fasciola hepatica infection. PLoS Neglected Tropical Dis-
eases, 10, e0005015.
Gaasenbeek, C. P. H., Moll, L., Cornelissen, J. B. W. J., Vellema, P., & Borg-
steede, F. H. M. (2001). An experimental study on triclabendazole resis-
tance of Fasciola hepatica in sheep. Veterinary Parasitology, 95, 37–43.
Gaasenbeek, C. P. H., Over, H. J., Noorman, N., & de Leeuw, W. A.
(1992). An epidemiological study of Fasciola hepatica in the Nether-
lands. Veterinary Quarterly, 14, 140–144.
Garcia-Campos, A., Ravida, A., Nguyen, D. L., Cwiklinski, K., Dalton, J. P.,
Hokke, C. H., . . . Mulcahy, G. (2016). Tegument glycoproteins and
cathepsins of Newly Excysted Juvenile Fasciola hepatica carry manno-
sidic and paucimannosidic N-glycans. PLoS Neglected Tropical Dis-
eases, 10, e0004688.
Girones, N., Valero, M. A., Garcıa-Bodelon, M. A., Chico-Calero, I.,
Punzon, C., Fresno, M., & Mas-Coma, S. (2007). Immune suppression
in advanced chronic fascioliasis: An experimental study in a rat
model. Journal of Infectious Diseases, 195, 1504–1512.
Glauert, A. M., Lammas, D. A., & Duffus, W. P. H. (1985). Ultrastrucural
observations on the interaction in vitro between bovine eosinophils
and juvenile Fasciola hepatica. Parasitology, 91, 459.
Golden, O., Flynn, R. J., Read, C., Sekiya, M., Donnelly, S. M., Stack, C.,
. . . Mulcahy, G. (2010). Protection of cattle against a natural infection
of Fasciola hepatica by vaccination with recombinant cathepsin L1
(rFhCL1). Vaccine, 28, 5551–5557.
Gordon, D., Zadoks, R., Skuce, P., & Sargison, N. (2012). Confirmation of
triclabendazole resistance in liver fluke in the UK: FIG 1. Veterinary
Record, 171, 159–160.
Gutierrez, A., Pointier, J.-P., Fraga, J., Jobet, E., Modat, S., Perez, R. T., . . .
Theron, A. (2003). Fasciola hepatica: Identification of molecular mark-
ers for resistant and susceptible Pseudosuccinea columella snail hosts.
Experimental Parasitology, 105, 211–218.
Gutierrez, A., Pointier, J. P., Yong, M., Sanchez, J., & Theron, A. (2003).
Evidence of phenotypic differences between resistant and susceptible
isolates of Pseudosuccinea columella (Gastropoda: Lymnaeidae) to Fas-
ciola hepatica (Trematoda: Digenea) in Cuba. Parasitology Research,
90, 129–134.
Guzman, E., Hope, J., Taylor, G., Smith, A. L., Cubillos-Zapata, C., & Char-
leston, B. (2014). Bovine T cells are a major regulatory T cell subset.
Journal of Immunology, 193, 208–222.
Hamilton, C. M., Dowling, D. J., Loscher, C. E., Morphew, R. M., Brophy,
P. M., & O’Neill, S. M. (2009). The Fasciola hepatica tegumental anti-
gen suppresses dendritic cell maturation and function. Infection and
Immunity, 77, 2488–2498.
Hanna, R. E. B., McMahon, C., Ellison, S., Edgar, H. W., Kajugu, P. E., Gor-
don, A., . . . Fairweather, I. (2015). Fasciola hepatica: A comparative
survey of adult fluke resistance to triclabendazole, nitroxynil and
closantel on selected upland and lowland sheep farms in Northern
14 | BEESLEY ET AL.
Ireland using faecal egg counting, coproantigen ELISA testing and
fluke histology. Veterinary Parasitology, 207, 34–43.
Heppleston, P. B. (1972). Life history and population fluctuations of Lym-
naea truncatula (Mull), the snail vector of fascioliasis. Journal of
Applied Ecology, 9, 235.
Heussler, V., Kaufmann, H., Strahm, D., Liz, J., & Dobbelaere, D. (1993).
DNA probes for the detection of Fasciola hepatica in snails. Molecular
and Cellular Probes, 7, 261–267.
Hodasi, J. K. M. (1972). The output of cercariae of Fasciola hepatica by
Lymnaea truncatula and the distribution of metacercariae on grass.
Parasitology, 64, 53.
Hodgkinson, J., Cwiklinski, K., Beesley, N. J., Paterson, S., & Williams, D.
J. L. (2013). Identification of putative markers of triclabendazole
resistance by a genome-wide analysis of genetically recombinant Fas-
ciola hepatica. Parasitology, 140, 1523–1533.
H€oglund, J., Dahlstr€om, F., Engstr€om, A., Hessle, A., Jakubek, E.-B., Sch-
nieder, T., . . . Sollenberg, S. (2010). Antibodies to major pasture
borne helminth infections in bulk-tank milk samples from organic and
nearby conventional dairy herds in south-central Sweden. Veterinary
Parasitology, 171, 293–299.
Howell, A., Baylis, M., Smith, R., Pinchbeck, G., & Williams, D. (2015). Epi-
demiology and impact of Fasciola hepatica exposure in high-yielding
dairy herds. Preventive Veterinary Medicine, 121, 41–48.
Humphreys, N. E., Xu, D., Hepworth, M. R., Liew, F. Y., & Grencis, R. K.
(2008). IL-33, a potent inducer of adaptive immunity to intestinal
nematodes. Journal of Immunology, 180, 2443–2449.
Ikebuchi, R., Konnai, S., Okagawa, T., Yokoyama, K., Nakajima, C., Suzuki,
Y., . . . Ohashi, K. (2014). Influence of PD-L1 cross-linking on cell
death in PD-L1-expressing cell lines and bovine lymphocytes.
Immunology, 142, 551–561.
Jones, R. A., Brophy, P. M., Mitchell, E. S., & Williams, H. W. (2016).
Rumen fluke (Calicophoron daubneyi) on Welsh farms: Prevalence, risk
factors and observations on co-infection with Fasciola hepatica. Para-
sitology, 144, 237–247.
Jones, R. A., Williams, H. W., Dalesman, S., & Brophy, P. M. (2015). Con-
firmation of Galba truncatula as an intermediate host snail for Cali-
cophoron daubneyi in Great Britain, with evidence of alternative
snail species hosting Fasciola hepatica. Parasites & Vectors, 8, 656–
660.
Kajugu, P. E., Hanna, R. E. B., Edgar, H. W., Forster, F. I., Malone, F. E.,
Brennan, G. P., & Fairweather, I. (2012). Specificity of a coproantigen
ELISA test for fasciolosis: Lack of cross-reactivity with Paramphisto-
mum cervi and Taenia hydatigena. Veterinary Record, 171, 502–502.
Kajugu, P. E., Hanna, R. E. B., Edgar, H. W., McMahon, C., Cooper, M.,
Gordon, A., . . . Fairweather, I. (2015). Fasciola hepatica: Specificity of
a coproantigen ELISA test for diagnosis of fasciolosis in faecal sam-
ples from cattle and sheep concurrently infected with gastrointestinal
nematodes, coccidians and/or rumen flukes (paramphistomes), under
field conditions. Veterinary Parasitology, 212, 181–187.
Kaplan, R. M., Dame, J. B., Reddy, G. R., & Courtney, C. H. (1995). A
repetitive DNA probe for the sensitive detection of Fasciola hepatica
infected snails. International Journal for Parasitology, 25, 601–610.
Karanikola, S., Kr€ucken, J., Ram€unke, S., de Waal, T., H€oglund, J., Charlier,
J., . . . Demeler, J. (2015). Development of a multiplex fluorescence
immunological assay for the simultaneous detection of antibodies
against Cooperia oncophora, Dictyocaulus viviparus and Fasciola hepat-
ica in cattle. Parasites & Vectors, 8, 335.
Kelley, J. M., Elliott, T. P., Beddoe, T., Anderson, G., Skuce, P., & Spithill,
T. W. (2016). Current threat of triclabendazole resistance in Fasciola
hepatica. Trends in Parasitology, 32, 458–469.
Kendall, S. R., & Ollerenshaw, C. B. (1963). The effect of nutrition on the
growth of Fasciola hepatica in its snail host. Proceedings of the Nutri-
tion Society, 22, 41–46.
Kuerpick, B., Schnieder, T., & Strube, C. (2013). Evaluation of a recombi-
nant cathepsin L1 ELISA and comparison with the Pourquier and ES
ELISA for the detection of antibodies against Fasciola hepatica. Veteri-
nary Parasitology, 193, 206–213.
Kumar, N., Anju, V., Gaurav, N., Chandra, D., Samanta, S., Gupta, S. C.,
. . . Raina, O. K. (2011). Vaccination of buffaloes with Fasciola gigan-
tica recombinant glutathione S-transferase and fatty acid binding pro-
tein. Parasitology Research, 110, 419–426.
Le, T. H., Nguyen, K. T., Nguyen, N. T. B., Doan, H. T. T., Le, X. T. K.,
Hoang, C. T. M., & De, N. V. (2012). Development and evaluation
of a single-step duplex PCR for simultaneous detection of Fasciola
hepatica and Fasciola gigantica (Family Fasciolidae, Class Trematoda,
Phylum Platyhelminthes). Journal of Clinical Microbiology, 50, 2720–
2726.
Mage, C., Bourgne, H., Toullieu, J.-M., Rondelaud, D., & Dreyfuss, G.
(2002). Fasciola hepatica and Paramphistomum daubneyi: Changes in
prevalences of natural infections in cattle and in Lymnaea truncatula
from central France over the past 12 years. Veterinary Research, 33,
439–447.
Maggioli, G., Acosta, D., Silveira, F., Rossi, S., Giacaman, S., Basika, T., . . .
Carmona, C. (2011). The recombinant gut-associated M17 leucine
aminopeptidase in combination with different adjuvants confers a
high level of protection against Fasciola hepatica infection in sheep.
Vaccine, 29, 9057–9063.
Manga-Gonzalez, Y., Gonzalez-Lanza, C., & Otero-Merino, C. B. (1991).
Natural infection of Lymnaea truncatula by the liver fluke Fasciola
hepatica in the Porma Basin, Leon, NW Spain. Journal of Helminthol-
ogy, 65, 15.
Martı́nez-Moreno, A., Jimenez-Luque, V., Camara, S., Martı́nez-Moreno,
F. J., Acosta, I., & Hernandez, S. (2000). Oxidative responses during
bacterial phagocytosis of polymorphonuclear leucocytes in primarily
and secondarily Fasciola hepatica infected goats. International Journal
for Parasitology, 30, 1013–1017.
Martınez-Perez, J. M., Robles-Perez, D., Rojo-Vazquez, F. A., & Martınez-
Valladares, M. (2012). Comparison of three different techniques to
diagnose Fasciola hepatica infection in experimentally and naturally
infected sheep. Veterinary Parasitology, 190, 80–86.
Martınez-Perez, J. M., Robles-Perez, D., Rojo-Vazquez, F. A., & Martınez-
Valladares, M. (2014). Immunological features of LPS from Ochrobac-
trum intermedium on sheep experimentally infected with Fasciola hep-
atica. Research in Veterinary Science, 97, 329–332.
Martınez-Sernandez, V., Mui~no, L., Perteguer, M. J., Garate, T., Mezo, M.,
Gonzalez-Warleta, M., . . . Ubeira, F. M. (2011). Development and
evaluation of a new lateral flow immunoassay for serodiagnosis of
human fasciolosis. PLoS Neglected Tropical Diseases, 5, e1376.
Martınez-Sernandez, V., Orbegozo-Medina, R. A., Gonzalez-Warleta, M.,
Mezo, M., & Ubeira, F. M. (2016). Rapid enhanced MM3-COPRO
ELISA for detection of Fasciola coproantigens. PLoS Neglected Tropical
Diseases, 10, e0004872.
Martınez-Valladares, M., & Rojo-Vazquez, F. A. (2016). Loop-mediated
isothermal amplification (LAMP) assay for the diagnosis of fasciolosis
in sheep and its application under field conditions. Parasites & Vec-
tors, 9, 73–77.
Mazeri, S., Sargison, N., Kelly, R. F., Bronsvoort, B. M., & Handel, I.
(2016). Evaluation of the performance of five diagnostic tests for Fas-
ciola hepatica infection in naturally infected cattle using a bayesian
no gold standard approach. PLoS One, 11, e0161621.
McCann, C. M., Baylis, M., & Williams, D. J. L. (2010). The development
of linear regression models using environmental variables to explain
the spatial distribution of Fasciola hepatica infection in dairy herds in
England and Wales. International Journal for Parasitology, 40, 1021–
1028.
McCole, D. F., Doherty, M. L., Torgerson, P. R., & Baird, A. W. (1998).
Local immune responses in colon from cattle infected with Fasciola
hepatica. International Journal for Parasitology, 28, 1733–1737.
McMahon, C., Edgar, H. W. J., Hanna, R. E. B., Ellison, S. E., Flanagan, A.
M., McCoy, M., . . . Fairweather, I. (2016). Liver fluke control on
BEESLEY ET AL. | 15
sheep farms in Northern Ireland: A survey of changing management
practices in relation to disease prevalence and perceived triclabenda-
zole resistance. Veterinary Parasitology, 216, 72–83.
McManus, D. P., & Dalton, J. P. (2006). Vaccines against the zoonotic
trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola
gigantica. Parasitology, 133, S43.
Meemon, K., & Sobhon, P. (2016). Development of fasciola vaccine in an
animal model. In Thomas, S. (Ed.), Vaccine design (pp. 123–133). New
York: Springer.
Meeusen, E., Lee, C. S., Rickard, M. D., & Brandon, M. R. (1995). Cellular
responses during liver fluke infection in sheep and its evasion by the
parasite. Parasite Immunology, 17, 37–45.
Mendes, R. E., Zafra, R., Perez-Ecija, R. A., Buffoni, L., Martınez-Moreno,
A., Tendler, M., & Perez, J. (2010). Evaluation of local immune
response to Fasciola hepatica experimental infection in the liver and
hepatic lymph nodes of goats immunized with Sm14 vaccine antigen.
Memorias do Instituto Oswaldo Cruz, 105, 698–705.
Mezo, M., Gonzalez-Warleta, M., Carro, C., & Ubeira, F. M. (2004). An
ultrasensitive capture elisa for detection of Fasciola hepatica
coproantigens in sheep and cattle using a new monoclonal antibody
(MM3). Journal of Parasitology, 90, 845–852.
Mezo, M., Gonzalez-Warleta, M., Castro-Hermida, J. A., Manga-
Gonzalez, M. Y., Peixoto, R., Mas-Coma, S., & Valero, M. A. (2013).
The wild boar (Sus scrofa Linnaeus, 1758) as secondary reservoir of
Fasciola hepatica in Galicia (NW Spain). Veterinary Parasitology, 198,
274–283.
Mezo, M., Gonzalez-Warleta, M., Castro-Hermida, J. A., Mui~no, L., &
Ubeira, F. M. (2010). Field evaluation of the MM3-SERO ELISA for
detection of anti-Fasciola IgG antibodies in milk samples from individ-
ual cows and bulk milk tanks. Parasitology International, 59, 610–615.
Mitchell, G. B., Maris, L., & Bonniwell, M. A. (1998). Triclabendazole-resis-
tant liver fluke in Scottish sheep. Veterinary Record, 143, 399.
Molina, E. C., & Skerratt, L. F. (2005). Cellular and humoral responses in
liver of cattle and buffaloes infected with a single dose of Fasciola
gigantica. Veterinary Parasitology, 131, 157–163.
Molina-Hernandez, V., Mulcahy, G., Perez, J., Martınez-Moreno, A., Don-
nelly, S., O’Neill, S. M., . . . Cwiklinski, K. (2015). Fasciola hepatica vac-
cine: We may not be there yet but we’re on the right road.
Veterinary Parasitology, 208, 101–111.
Moll, L., Gaasenbeek, C. P. H., Vellema, P., & Borgsteede, F. H. M.
(2000). Resistance of Fasciola hepatica against triclabendazole in cat-
tle and sheep in The Netherlands. Veterinary Parasitology, 91, 153–
158.
Mooney, L., Good, B., Hanrahan, J. P., Mulcahy, G., & de Waal, T. (2009).
The comparative efficacy of four anthelmintics against a natural
acquired Fasciola hepatica infection in hill sheep flock in the west of
Ireland. Veterinary Parasitology, 164, 201–205.
Mulcahy, G. (1998). Correlation of specific antibody titre and avidity with
protection in cattle immunized against Fasciola hepatica. Vaccine, 16,
932–939.
Mulcahy, G., O’Connor, F., Clery, D., Hogan, S. F., Dowd, A. J., Andrews,
S. J., & Dalton, J. P. (1999). Immune responses of cattle to experi-
mental anti-Fasciola hepatica vaccines. Research in Veterinary Science,
67, 27–33.
Munita, M. P., Rea, R., Bloemhoff, Y., Byrne, N., Martinez-Ibeas, A. M., &
Sayers, R. G. (2016). Six-year longitudinal study of Fasciola hepatica
bulk milk antibody ELISA in the dairy dense region of the Republic
Ireland. Preventive Veterinary Medicine, 134, 16–25.
Nansen, P., Frandsen, F., & Christensen, N. Ø. (1976). A study on snail
location by Fasciola hepatica using radioisotopically labelled miracidia.
Parasitology, 72, 163.
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K.
A., . . . McKenzie, A. N. J. (2010). Nuocytes represent a new innate
effector leukocyte that mediates type-2 immunity. Nature, 464,
1367–1370.
Notomi, T. (2000). Loop-mediated isothermal amplification of DNA.
Nucleic Acids Research, 28, 63e–63.
Novobilsky, A., Amaya Solis, N., Skarin, M., & H€oglund, J. (2016). Assess-
ment of flukicide efficacy against Fasciola hepatica in sheep in Swe-
den in the absence of a standardised test. International Journal for
Parasitology: Drugs and Drug Resistance, 6, 141–147.
Novobilsky, A., & H€oglund, J. (2015). First report of closantel treatment
failure against Fasciola hepatica in cattle. International Journal for Par-
asitology: Drugs and Drug Resistance, 5, 172–177.
Novobilsky, A., Kasny, M., Beran, L., Rondelaud, D., & H€oglund, J. (2013).
Lymnaea palustris and Lymnaea fuscus are potential but uncommon
intermediate hosts of Fasciola hepatica in Sweden. Parasites & Vec-
tors, 6, 251.
Noya, V., Brossard, N., Berasaın, P., Rodrıguez, E., Chiale, C., Mazal, D.,
. . . Freire, T. (2015). A mucin-like peptide from Fasciola hepatica
induces parasite-specific Th1-type cell immunity. Parasitology
Research, 115, 1053–1063.
Olah, S., van Wyk, J. A., Wall, R., & Morgan, E. R. (2015). FAMACHA ©:
A potential tool for targeted selective treatment of chronic fasciolosis
in sheep. Veterinary Parasitology, 212, 188–192.
Oliphant, C. J., Hwang, Y. Y., Walker, J. A., Salimi, M., Wong, S. H.,
Brewer, J. M., . . . McKenzie, A. N. J. (2014). MHCII-mediated dialog
between group 2 innate lymphoid cells and CD4+ T cells potentiates
type 2 immunity and promotes parasitic helminth expulsion. Immu-
nity, 41, 283–295.
Ollerenshaw, C. B. (1959). The ecology of the liver fluke (Fasciola hepat-
ica). Veterinary Record, 71, 957–963.
Ollerenshaw, C. (1971). Some observations on the epidemiology of fasci-
oliasis in relation to the timing of molluscicide applications in the
control of the disease. Veterinary Record, 88, 152–164.
Ollerenshaw, C. B. R., & Rowlands, W. T. (1959). A method of forecasting
the incidence of fascioliasis in Anglesey. Veterinary Record, 71, 591–
598.
O’Neill, S. M., Brady, M. T., Callanan, J. J., Mulcahy, G., Joyce, P., Mills, K.
H. G., & Dalton, J. P. (2000). Fasciola hepatica infection downregu-
lates Th1 responses in mice. Parasite Immunology, 22, 147–155.
Osman, M. M., Rashwan, E., & Farag, H. F. (1995). Phagocytic activity of
neutrophils in human fasciolosis before and after treatment. Journal
of the Egyptian Society of Parasitology, 25, 321–327.
Overend, D. J., & Bowen, F. L. (1995). Resistance of Fasciola hepatica to
triclabendazole. Australian Veterinary Journal, 72, 275–276.
Palmer, D. G., Lyon, J., Palmer, M. A., & Forshaw, D. (2014). Evaluation
of a copro-antigen ELISA to detect Fasciola hepatica infection in
sheep, cattle and horses. Australian Veterinary Journal, 92, 357–361.
Piacenza, L., Acosta, D., Basmadjian, I., & Carmona, C. (1998). Vaccination
against infection with Fasciola hepatica in sheep with cathepsin L pro-
teinases and with leucine aminopeptidase induce high levels of pro-
tection. Parasitology International, 47, 266.
Piedrafita, D., Estuningsih, E., Pleasance, J., Prowse, R., Raadsma, H. W.,
Meeusen, E. N. T., & Spithill, T. W. (2007). Peritoneal lavage cells of
Indonesian thin-tail sheep mediate antibody-dependent superoxide
radical cytotoxicity in vitro against newly excysted juvenile Fasciola
gigantica but not juvenile Fasciola hepatica. Infection and Immunity,
75, 1954–1963.
Pleasance, J., Raadsma, H. W., Estuningsih, S. E., Widjajanti, S., Meeusen,
E., & Piedrafita, D. (2011). Innate and adaptive resistance of Indone-
sian Thin Tail sheep to liver fluke: A comparative analysis of Fasciola
gigantica and Fasciola hepatica infection. Veterinary Parasitology, 178,
264–272.
Pleasance, J., Wiedosari, E., Raadsma, H. W., Meeusen, E., & Piedrafita,
D. (2011). Resistance to liver fluke infection in the natural sheep host
is correlated with a type-1 cytokine response. Parasite Immunology,
33, 495–505.
Poitou, I., Baeza, E., & Boulard, C. (1993). Kinetic responses of parasite-
specific antibody isotypes, blood leucocyte pattern and lymphocyte
16 | BEESLEY ET AL.
subsets in rats during primary infestation with Fasciola hepatica.
Veterinary Parasitology, 49, 179–190.
Ravida, A., Aldridge, A. M., Driessen, N. N., Heus, F. A. H., Hokke, C. H.,
& O’Neill, S. M. (2016). Fasciola hepatica surface coat glycoproteins
contain mannosylated and phosphorylated N-glycans and exhibit
immune modulatory properties independent of the mannose recep-
tor. PLoS Neglected Tropical Diseases, 10, e0004601.
Relf, V., Good, B., Hanrahan, J. P., McCarthy, E., Forbes, A. B., & deWaal,
T. (2011). Temporal studies on Fasciola hepatica in Galba truncatula in
the west of Ireland. Veterinary Parasitology, 175, 287–292.
Relf, V., Good, B., McCarthy, E., & de Waal, T. (2009). Evidence of Fasci-
ola hepatica infection in Radix peregra and a mollusc of the family
Succineidae in Ireland. Veterinary Parasitology, 163, 152–155.
Reynecke, D. P., van Wyk, J. A., Gummow, B., Dorny, P., & Boomker, J.
(2011). Validation of the FAMACHA© eye colour chart using sensitiv-
ity/specificity analysis on two South African sheep farms. Veterinary
Parasitology, 177, 203–211.
Rinaldi, L., Biggeri, A., Musella, V., De Waal, T., Hertzberg, H., Mavrot, F.,
. . . Catelan, D. (2015). Sheep and Fasciola hepatica in Europe: The
GLOWORM experience. Geospatial Health, 9, 309.
Robles-Perez, D., Martınez-Perez, J. M., Rojo-Vazquez, F. A., & Martınez-
Valladares, M. (2013). The diagnosis of fasciolosis in feces of sheep
by means of a PCR and its application in the detection of anthelmin-
tic resistance in sheep flocks naturally infected. Veterinary Parasitol-
ogy, 197, 277–282.
Robles-Perez, D., Martınez-Perez, J. M., Rojo-Vazquez, F. A., &
Martınez-Valladares, M. (2014). Development of an egg hatch
assay for the detection of anthelmintic resistance to albendazole in
Fasciola hepatica isolated from sheep. Veterinary Parasitology, 203,
217–221.
Robles-Perez, D., Martınez-Perez, J. M., Rojo-Vazquez, F. A., & Martınez-
Valladares, M. (2015). Screening anthelmintic resistance to triclaben-
dazole in Fasciola hepatica isolated from sheep by means of an egg
hatch assay. BMC Veterinary Research, 11, 226–230.
Rojo-Vazquez, F. A., Meana, A., Valcarcel, F., & Martınez-Valladares, M.
(2012). Update on trematode infections in sheep. Veterinary Parasitol-
ogy, 189, 15–38.
Rondelaud, D., & Dreyfuss, G. (1997). Variability of Fasciola infections in
Lymnaea truncatula as a function of snail generation and snail activity.
Journal of Helminthology, 71, 161.
Rondelaud, D., Hourdin, P., Vignoles, P., Dreyfuss, G., & Cabaret, J. (2011).
The detection of snail host habitats in liver fluke infected farms by use
of plant indicators. Veterinary Parasitology, 181, 166–173.
Rondelaud, D., Vignoles, P., & Dreyfuss, G. (2004). Fasciola hepatica: The
developmental patterns of redial generations in naturally infected
Galba truncatula. Parasitology Research, 94, 183–187.
Rondelaud, D., Vignoles, P., & Dreyfuss, G. (2007). Parasite development
and visceral pathology in Galba truncatula co-infected with Fasciola
hepatica and Paramphistomum daubneyi. Journal of Helminthology, 81,
317–322.
Rondelaud, D., Vignoles, P., & Dreyfuss, G. (2015). Larval trematode
infections in Galba truncatula (Gastropoda, Lymnaeidae) from the
Brenne Regional Natural Park, central France. Journal of Helminthol-
ogy, 90, 256–261.
Salimi-Bejestani, M. R., McGarry, J. W., Felstead, S., Ortiz, P., Akca, A., &
Williams, D. J. L. (2005). Development of an antibody-detection
ELISA for Fasciola hepatica and its evaluation against a commercially
available test. Research in Veterinary Science, 78, 177–181.
Sargison, N. D., & Scott, P. R. (2011). Diagnosis and economic conse-
quences of triclabendazole resistance in Fasciola hepatica in a sheep
flock in south-east Scotland. Veterinary Record, 168, 159–159.
Schweizer, G., Meli, M. L., Torgerson, P. R., Lutz, H., Deplazes, P., &
Braun, U. (2007). Prevalence of Fasciola hepatica in the intermediate
host Lymnaea truncatula detected by real time TaqMan PCR in
populations from 70 Swiss farms with cattle husbandry. Veterinary
Parasitology, 150, 164–169.
Selemetas, N., Ducheyne, E., Phelan, P., O’Kiely, P., Hendrickx, G., & De
Waal, T. (2015). Spatial analysis and risk mapping of Fasciola hepatica
infection in dairy herds in Ireland. Geospatial Health, 9, 281.
Sokol, C. L., Barton, G. M., Farr, A. G., & Medzhitov, R. (2007). A mecha-
nism for the initiation of allergen-induced T helper type 2 responses.
Nature Immunology, 9, 310–318.
Spithill, T. W. S., Smooker, P. M., & Copeman, D. B. (1999). Fasciola
gigantica: Epidemiology, control, immunology and molecular biology.
In J. P. Dalton (Ed.), Fasciolosis (pp. 465–525). CABI publishing: CABI
Publishing.
Taylor, B. C., Zaph, C., Troy, A. E., Du, Y., Guild, K. J., Comeau, M. R., &
Artis, D. (2009). TSLP regulates intestinal immunity and inflammation
in mouse models of helminth infection and colitis. Journal of Experi-
mental Medicine, 206, 655–667.
Thomas, I., Coles, G. C., & Duffus, K. (2000). Triclabendazole-resistant
Fasciola hepatica in southwest Wales. Veterinary Record, 146, 200.
Tliba, O., Chauvin, A., Le Vern, Y., Boulard, C., & Sibille, P. (2002). Evalua-
tion of the hepatic NK cell response during the early phase of Fasci-
ola hepatica infection in rats. Veterinary Research, 33, 327–332.
Toet, H., Piedrafita, D. M., & Spithill, T. W. (2014). Liver fluke vaccines in
ruminants: Strategies, progress and future opportunities. International
Journal for Parasitology, 44, 915–927.
Turner, J., Howell, A., McCann, C., Caminade, C., Bowers, R. G., Williams,
D., & Baylis, M. (2016). A model to assess the efficacy of vaccines
for control of liver fluke infection. Scientific Reports, 6, 1–13.
Van Milligen, F. J., Cornelissen, J. B., Hendriks, I. M., Gaasenbeek, C. P.,
& Bokhout, B. A. (1998). Protection of Fasciola hepatica in the gut
mucosa of immune rats is associated with infiltrates of eosinophils,
IgG1 and IgG2a antibodies around the parasites. Parasite Immunology,
20, 285–292.
Vignoles, P., Rondelaud, D., & Dreyfuss, G. (2010). Characteristics of Fas-
ciola hepatica infections in Galba truncatula originating from riverbank
populations. Journal of Helminthology, 85, 28–32.
Villa-Mancera, A., & Mendez-Mendoza, M. (2012). Protection and anti-
body isotype responses against Fasciola hepatica with specific anti-
body to pIII-displayed peptide mimotopes of cathepsin L1 in sheep.
Veterinary Journal, 194, 108–112.
Villa-Mancera, A., Quiroz-Romero, H., Correa, D., Ibarra, F., Reyes-PERez,
M., Reyes-Vivas, H., . . . Alonso, R. A. (2008). Induction of immunity
in sheep to Fasciola hepatica with mimotopes of cathepsin L selected
from a phage display library. Parasitology, 135, 1437.
Villa-Mancera, A., Reynoso-Palomar, A., Utrera-Quintana, F., & Carreon-
Luna, L. (2013). Cathepsin L1 mimotopes with adjuvant Quil A
induces a Th1/Th2 immune response and confers significant protec-
tion against Fasciola hepatica infection in goats. Parasitology Research,
113, 243–250.
van der Voort, M., Charlier, J., Lauwers, L., Vercruysse, J., Van Huylen-
broeck, G., & Van Meensel, J. (2013). Conceptual framework for ana-
lysing farm-specific economic effects of helminth infections in
ruminants and control strategies. Preventive Veterinary Medicine, 109,
228–235.
van der Voort, M., Van Meensel, J., Lauwers, L., Van Huylenbroeck, G., &
Charlier, J. (2015). The relation between input-output transformation
and gastrointestinal nematode infections on dairy farms. Animal, 10,
274–282.
van der Voort, M., Van Meensel, J., Lauwers, L., Vercruysse, J., Van
Huylenbroeck, G., & Charlier, J. (2014). A stochastic frontier approach
to study the relationship between gastrointestinal nematode infec-
tions and technical efficiency of dairy farms. Journal of Dairy Science,
97, 3498–3508.
Vukman, K. V., Adams, P. N., Dowling, D., Metz, M., Maurer, M., &
O’Neill, S. M. (2013). The effects of Fasciola hepatica tegumental
BEESLEY ET AL. | 17
antigens on mast cell function. International Journal for Parasitology,
43, 531–539.
Walsh, K. P., Brady, M. T., Finlay, C. M., Boon, L., & Mills, K. H. G.
(2009). Infection with a helminth parasite attenuates autoimmunity
through TGF-b-mediated suppression of Th17 and Th1 responses.
Journal of Immunology, 183, 1577–1586.
Wedrychowicz, H., Kesik, M., Kaliniak, M., Kozak-Cieszczyk, M., Jedlina-
Panasiuk, L., Jaros, S., & Plucienniczak, A. (2007). Vaccine potential of
inclusion bodies containing cysteine proteinase of Fasciola hepatica in
calves and lambs experimentally challenged with metacercariae of the
fluke. Veterinary Parasitology, 147, 77–88.
Wesołowska, A., Zawistowska-Deniziak, A., Norbury, L. J., Wilkowski, P.,
Pyziel, A. M., Zygner, W., & Wedrychowicz, H. (2017). Lymphocyte
responses of rats vaccinated with cDNA encoding a phosphoglycer-
ate kinase of Fasciola hepatica (FhPGK) and F. hepatica infection. Par-
asitology International, https://doi.org/doi.org/10.1016/j.parint.2017.
04.002.
Yap, H. Y., & Smooker, P. M. (2016). Development of experimental vacci-
nes against liver flukes. In H. Y. Yap (Ed.), Vaccine design (pp. 135–
151). New York: Springer.
Zafra, R., Perez-Ecija, R. A., Buffoni, L., Mendes, R. E., Martınez-Moreno,
A., Martınez-Moreno, F. J., . . . Perez, J. (2010). Evaluation of hepatic
damage and local immune response in goats immunized with native
glutathione S-transferase of Fasciola hepatica. Journal of Comparative
Pathology, 143, 110–119.
Zafra, R., Perez-Ecija, R. A., Buffoni, L., Moreno, P., Bautista, M. J.,
Martınez-Moreno, A., . . . Perez, J. (2013). Early and late peritoneal
and hepatic changes in goats immunized with recombinant cathepsin
L1 and infected with Fasciola hepatica. Journal of Comparative Pathol-
ogy, 148, 373–384.
Zafra, R., Perez-Ecija, R. A., Buffoni, L., Pacheco, I. L., Martınez-Moreno,
A., LaCourse, E. J., . . . Perez, J. (2013). Early hepatic and peritoneal
changes and immune response in goats vaccinated with a recombi-
nant glutathione transferase sigma class and challenged with Fasciola
hepatica. Research in Veterinary Science, 94, 602–609.
Zhang, W. Y., Moreau, E., Hope, J. C., Howard, C. J., Huang, W. Y., &
Chauvin, A. (2005). Fasciola hepatica and Fasciola gigantica: Compar-
ison of cellular response to experimental infection in sheep. Experi-
mental Parasitology, 111, 154–159.
How to cite this article: Beesley NJ, Caminade C, Charlier J,
et al. Fasciola and fasciolosis in ruminants in Europe:
Identifying research needs. Transbound Emerg Dis.
2017;00:000–000. https://doi.org/10.1111/tbed.12682
18 | BEESLEY ET AL.
